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ABSTRACT 






Methoxychlor, an organochlorine pesticide, is released into the environment as a result of 
its agricultural, home and veterinary use. Following in vivo administration, it is quickly 
metabolized by liver to the proposed active agent, HPTE. Both methoxychlor and HPTE 
have been shown to exhibit weak estrogenic and antiandrogenic activities, and they are 
thought to exert their effects through estrogen and androgen receptors. In vivo exposure 
to methoxychlor in laboratory animals causes ovarian atrophy and impaired ovarian 
steroid production. The effect of methoxychlor and its mechanism(s) of action on ovarian 
steroidogenesis are not clearly defined. The central hypothesis of these studies is that 
exposure to HPTE directly inhibits ovarian steroid biosynthesis, which is able to cause an 
imbalance in circulating progesterone and estradiol levels. The specific aims of the 
project are: (1) To pinpoint the potential effect of HPTE on ovarian steroidogenesis, 
(2) To examine the possible mechanism(s) of action of HPTE on ovarian 
steroidogenesis, (3) To evaluate the potential effect of HPTE on ovarian luteal 
steroidogenesis, (4) To determine whether in vivo exposure to methoxychlor lowers 
serum progesterone or estradiol levels and/or inhibits ex vivo ovarian 
steroidogenesis.  Results obtained from the in vitro studies demonstrated that HPTE 
directly inhibits progesterone formation by PMSG-primed rat ovarian theca, granulosa 
and luteal cells, and this decline in progesterone corresponded to a decline in P450 
cholesterol side-chain cleavage activity, which converts cholesterol to pregnenolone in 
the pathway of progesterone and estrogen biosynthesis. In addition, the percentage 
decrease in progesterone production was greater than the declines in estradiol and 
androgen formation suggesting that HPTE may increase the estrogen/progesterone ratio. 
Further, this effect of HPTE action could be observed at the environmentally relevant 
concentrations of 10-50 nM and does not appear to be mediated through ER or AR 
signaling pathways. Consistent with the HPTE action in the in vitro studies, in vivo 
exposure to methoxychlor lowers circulating progesterone levels in the immature rats not 
treated with gonadotropins; however, the exposure of animals to gonadotropins leads to 
an ex vivo increase in progesterone production by isolated ovarian theca cells and no 
change in circulating progesterone levels. This suggests that the pattern of active steroids 
secreted ex vivo by ovarian cells in response to methoxychlor exposure differs from that 
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There are synthetic and naturally occurring compounds that have the potential to mimic 
and/or interfere with normal functioning of the endocrine system that regulates 
homeostasis, reproduction, development and behavior [1]. These endocrine-disrupting 
chemicals (EDCs) are capable of exerting estrogenic, antiestrogenic, androgenic, 
antiandrogenic or thyroid hormone receptor-induced responses [2]. Many of these EDCs 
are used as pesticides (e.g., dichlorodiphenyltrichloroethane, DDT; methoxychlor; and 
vinclozolin), surfactants (e.g., octylphenol and bisphenol A), plasticizers (phthalates), or 
industrial compounds (e.g., polychlorinated biphenyl, PCB; and 2,3,7,8-
tetrachlorodibenzo-p-dioxin,  TCDD). Because of the widespread presence of these 
chemicals in daily life, humans are exposed, starting at conception, to various 
combinations of them. In fact, these compounds have been detected at low concentrations 
in almost all human samples including urine, blood, semen, ovarian follicular fluid, 
amniotic fluid and breast milk (reviewed in [3-5]). Recent articles have proposed that 
EDCs are involved in the etiology of many reproductive problems, including impaired 
sperm quality, ovarian failure, polycystic ovarian syndrome (PCOS), and endometriosis, 
as well as premature puberty and menopause [6-8]. It has been reported that these 
reproductive disorders have progressively increased over the past 4-5 decades along with 
the infertility rate in the US [9,10]. However, the casual connection between exposure to 
potential EDCs and the increased prevalence in reproductive disorders is controversial 
and not fully accepted [4,6].  Growing evidence from wildlife, epidemiological and 
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laboratory studies suggest that exposure to various chemicals, starting in utero, could 
adversely affect adult reproductive health. 
 
In wildlife, adverse reproductive effects including decreased fertility, increased 
reproductive tract abnormalities, and feminization of male and masculization of female 
characteristics were reported in birds, fish and mammals in areas contaminated with 
EDCs (reviewed in [11]). In farmers or people who live near farms, exposure to 
pesticides was linked to reduced fertility, sperm damage, menstrual alterations and 
increased time to pregnancy and increased spontaneous miscarriage rates (reviewed in 
[12]). In humans, experience with the pharmaceutical diethylstilbestrol (DES) 
demonstrated that prenatal exposure to a synthetic estrogen could adversely affect 
reproductive physiology and impair fertility later in life. In utero exposure to DES, 
prescribed to reduce miscarriage and premature labor, resulted in reproductive 
abnormalities later in life including increased risk of vaginal adenocarcinomas at puberty 
and development of breast cancer [13,14]. Supporting these adverse reproductive effects 
of environmental and occupational levels of EDCs, in vivo exposure to relatively higher 
doses of EDCs in laboratory animals has resulted in similar adverse reproductive 
outcomes including decreased fertility, precocious puberty, altered estrous cycle 
expression and gonadal atrophy in rodents and monkeys (reviewed in [15-17]). 
 
One model endocrine disrupter that has the potential to adversely affect reproduction 
is the pesticide methoxychlor (MC). This dissertation focuses on the effects of MC on 
ovarian steroidogenesis. The following section will provide an overview of the 
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metabolism of MC and the potential adverse reproductive effects of MC and its proposed 
active metabolite, HPTE. This review will also discuss ovarian steroid hormone synthesis 
and how biosynthesis is regulated..  
 
Methoxychlor  
MC is an organochlorine insecticide that is effective against a wide variety of insects. It is 
released into the environment as a result of its application on fruits, vegetables, forage 
crops, livestock and pets [18]. MC dissolves poorly in water and can persist in soil for 
more than a year after its application. It is degraded to dechlorinated, dehydrochlorinated 
and demethylated products primarily by microorganisms in the soil or water, and this is 
affected by the level of aeration of the soil [18]. People are exposed to MC and/or its 
metabolites through inhalation and skin contact during its application, as well as by 
ingestion of contaminated food and water [18]. Low levels of MC (ranging from 1-4 
µg/kg) have been detected in dairy products, grains, fruits and vegetables. Higher levels 
(10-120 µg/kg) have been infrequently reported in fish [18].   
 
Following in vivo administration, MC is rapidly eliminated from the body and does not 
bioaccumulate in the fat tissue even though it is highly lipophilic (100,000 times higher 
concentration in the lipid than aqueous phase) [18,19]. MC is converted to demethylated 
and hydroxylated metabolites mainly by liver cytochrome P450 (CYP) enzymes in both 
rodents and humans (Figure 1) [19-21]. There is evidence also for peripheral metabolism 
of MC. For example, the ovarian surface epithelium expresses P450 enzymes that are 
capable of metabolizing MC [22].  Mechanisms of action of each of these metabolites are 
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believed to differ; however, among its metabolites, 2,2-bis-(p-hydroxyphenyl)-1,1,1-
trichloroethane (HPTE) is known to bind to the estrogen receptor (ER) with a higher 
affinity than MC itself [23]. 
 
In vivo exposure to MC has been reported to cause embryonic toxicity, precocious 
puberty, decreased fertility and declines in gonadal weight and serum gonadal steroid 
levels in both male and female rodents [24-27]. In female rats, chronic exposure to MC 
resulted in acceleration of in vaginal opening, disruption of the estrous cycle, reduction in 
pregnancy rate and a reduction in the number of live pups delivered [28-30]. Further, MC 
administration increased uterine weight [31] but caused ovarian atrophy [32-34] and a 
dose-dependent decline in the number of follicles and steroid output [29,34]. Some of 
these effects were attributed to MC action within the hypothalamic-pituitary axis based 
on the observations that gonadotropin secretion was altered [24,30]. However, other 
studies have disputed impaired gonadotropin secretion by MC exposure [30,35], and 
recent in vitro studies suggested direct effects of MC on the gonads [36-39]. 
 
Lowest-Observed-Adverse-Effect Levels of Methoxychlor 
The most sensitive responses to MC has been seen in female animals, and it appears to 
reduce ovulation rate and to cause ovarian atrophy in 4-month old gonadotropin-primed 
adult mice following neonatal i.p. exposure to 0.1-0.5 mg/kg/day MC [32]. Another in 
vivo study reported delayed vaginal opening and decreased ovary weight on postnatal day 
46 in female rats following exposure to 5 mg/kg/day of MC (the lowest dose tested) 
during prenatal day 7 to postnatal day 42 [24]. Although MC doses in these in vivo 
studies are higher than environmentally relevant levels, in vitro studies suggested that 
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MC might alter reproduction at more relevant concentrations. For example, recent studies 
reported that exposure to 10-100 µg/ml MC in cultured mouse ovarian follicles 
compromised follicle growth and 100 µg/ml of MC caused antral follicle atresia [36,39]. 
Furthermore, 100 nM of the MC metabolite HPTE inhibited the production of androgens 
by cultured rat Leydig cells [37]. 
 
Mechanism of Action 
In vivo, MC is estrogenic, although its binding affinity for estrogen receptor α (ERα) is 
ten thousand times less than 17β-estradiol (estradiol) [40]. MC mimics estradiol action in 
the female rodent reproductive tract, causing an uterotropic response in ovariectomized 
rats [41,42]. In female rodents, exposure to MC caused the proliferation of ovarian 
surface epithelium through estrogen receptor (ER)-linked mechanisms [43]. Molecular 
studies revealed that MC and estradiol regulate the activity of many of the same uterine 
proteins in ovariectomized rodents, including ER [44] and epidermal growth factor 
receptor [45]. However, estradiol and MC do not exhibit additive or synergistic effects in 
the reproductive tract of adult ovariectomized mice. For example, combining MC with 
estradiol suggested some antagonistic effects of MC, as reproductive tract weight changes 
and induction of uterine albumin levels following treatment with estradiol was blocked 
by co-administration of MC [46]. Neonatal exposure of mice to lower doses (~6.8 mg/kg 
or ~13.5 mg/kg) of MC led to a delay in the normal reproductive aging process of ovaries 
(which is accelerated by estradiol administration) at six months of age [30]. 
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In addition to estrogenic and antiestrogenic properties of MC, recent studies suggested 
that MC could act through other mechanisms. Ghosh et al. demonstrated that MC induced 
an increase in mRNA levels of two estrogen-responsive genes, lactoferrin and glucose-6-
phosphate dehydrogenase, in ovariectomized ER  knockout mice that could not be 
blocked by administration of the pure antiestrogen ICI 182,780 [47]. Moreover, it has 
been shown that MC induced atresia of antral follicles by the activation of Bcl-2- and 
Bax-mediated signal transduction [39] and oxidative stress pathways [33].  
 
Proposed Active Metabolite HPTE 
It is generally acknowledged that the physiological effects of in vivo MC treatment are 
mediated mainly by the metabolite, 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane 
(HPTE) [48]. Both MC and HPTE have weak estrogenic and antiandrogenic activities 
[49,50]. However, HPTE binds with higher affinity to the ER [48] and is a more potent 
androgen receptor (AR) blocker [49]. In the uterus, which expresses  predominantly ERα, 
it was shown that HPTE and estradiol acted similarly to regulate most gene families 
including gonadotropin-releasing hormone [51], uterine insulin-like growth factor 1 [52], 
the progesterone receptor (PR), ERα and AR [53]. In contrast, the induction of ovarian 
cathepsin B by estradiol was reversed after co-treatment with HPTE, and ERβ expression 
was induced similarly by HPTE and an AR blocker hydroxyflutamide (flutamide) but not 
by estradiol [53]. In human hepatoma cells (HepG2), HPTE acted as an ERα agonist; 
however, it was antagonistic to ERβ and AR [54]. Although it was generally thought that 
HPTE exerts its effect through receptor-mediated pathways, some actions of HPTE may 
not be mediated through the ER or AR. For example, Murono et al. demonstrated that the 
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concomitant addition of the “pure” antiestrogen, ICI 182,780 (ICI), did not block the 
inhibition of HPTE on testosterone formation and the exposure to the antiandrogenic 
hydroxyflutamide or vinclozolin alone did not mimic the effect of HPTE on androgen 
production by cultured fetal Leydig cells from neonatal male rats [38].  
 
Effects of MC on Ovarian Steroidogenesis 
Limited data is available on the effects of MC on ovarian steroidogenesis. In one study 
where MC (0, 100 - 500 mg/kg) was administered by gavage to adult female rats on days 
1-8 of pregnancy, serum progesterone levels declined beginning at the 100 mg/kg dose 
[26] (under these conditions, most of the progesterone would have originated from luteal 
tissue). In a follow-up study, adult female rats were exposed daily to in vivo MC (0, 25-
500 mg/kg) during the first 8 days of pregnancy, and serum and the ex vivo production of 
progesterone and estradiol by ovarian cells was determined [29]. Similar to the initial 
study, serum progesterone levels declined starting at the 50 mg/kg dose, then levels were 
progressively lower at higher doses of MC; however, serum estradiol levels were 
unaffected by exposure to MC. When minced ovarian tissue from these animals was 
incubated without or with hCG for 1 h, progesterone production in the tissue exposed in 
vivo to MC, was no different than control; however, both basal and hCG-stimulated 
testosterone and estradiol formation from these same ovarian tissue declined starting at 
the 200 mg/kg dose of MC [29]. Another study with young mature female mice 
demonstrated that the daily i.p. administration of MC for 20 days had no effect on serum 
estradiol levels even though atresia of antral follicles increased in relation to the dose of 
MC [36].  In vitro studies with ovarian granulosa cells and granulosa cell lines reported 
that progesterone production was inhibited by exposure to MC or HPTE [55-57]; 
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suggesting that ovarian steroid-secreting cells could be directly affected by both MC and 
HPTE.  In adult male rats, in vivo exposure to MC resulted in  a reduction in serum 
testosterone levels and a decline in the ex vivo Leydig cell testosterone formation and 
P450 cholesterol side-chain cleavage (P450scc) activity [58], supporting in vitro studies 
where HPTE directly inhibited testosterone formation by cultured rat Leydig cells 
[37,38]. 
 
Ovarian Steroidogenesis  
Steroid hormone production by the ovary is essential for oocyte and follicle development 
as well as for the initiation and maintenance of pregnancy in mammals [59]. The ovary 
produces progestins, androgens and estrogens in a sequential manner, with each serving 
as substrate for the subsequent steroid, and the levels secreted vary with the stage of 
follicle development [60]. The preovulatory follicle (multiple follicles in rodents) 
secretes mainly estrogens (estradiol and estrone) along with androgens 
(dehydroepiandrostenodione, androstenedione and testosterone), which reach higher 
levels shortly before ovulation [61]. The corpus luteum primarily produces progesterone 
along with estrogens [61]. Timely production of the ovarian steroids and the subsequent 
activation of local steroid-mediated signaling is important for development of the oocyte 
and follicles [62]. For example, mice with reduced expression of ERs or lacking AR are 
reported to have abnormal follicle growth, ovarian failure and altered oocyte maturation 
[63-66]. Mice lacking PRs do not ovulate in response to gonadotropins [67].  In addition, 
excess ovarian steroid secretion can lead to significant ovarian pathology, as increased 
ovarian steroid signaling leads to polycystic ovarian syndrome (PCOS), which is 
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characterized by excess androgen production, abnormal follicle growth and anovulation 
in women [62].   
 
Ovarian Follicle 
The main steroid-secreting ovarian cells (theca and granulosa) are organized in a 
structure called the follicle, which represents the basic functional unit of the ovary with 
respect to oocyte development and steroid production [61]. Follicles in varying 
developmental stages (primordial, primary, preantral, antral, preovulatory and corpus 
luteum) are embedded in connective tissue of the ovarian cortex [61]. The majority of 
these follicles are primordial (small resting follicles that contains an immature oocyte and 
a single layer of flattened granulosa cells enclosed by a basal lamina), and they do not 
have theca cells associated with them [68].  Only after development has proceeded to the 
preantral stage when a second layer of cuboidal granulosa cells begin to appear, do the 
first theca cells begin to differentiate from the interstitial cells of the ovarian stroma [68]. 
Prior to puberty, resting follicles can enter the growing pool, and they can progress to the 
antral stage at which point they inevitably undergo atresia [59]. Although gonadotropins 
stimulate growth and differentiation of preantral follicles, follicles can develop up to the 
antral stage in the absence of gonadotropins [59]. Starting at  puberty, a cohort of antral 
follicles escapes apoptosis due to follicle stimulating hormone (FSH) action [59] and 
develops into mature follicles destined to either regress or form the corpus luteum 
following ovulation (figure 2). As the selected follicle grows, its antrum is engorged with 
follicular fluid, both theca and granulosa cells proliferate, and they produce increasing 
levels of steroid hormones. In theca cells, luteinizing hormone (LH) receptors and the 
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enzyme 17α-hydroxylase/17,20-lyase (P450c17), which converts pregnenolone and 
progesterone to dehydroepiandrosterone (DHEA) and androstenedione, respectively, are 
expressed primarily. In granulosa cells, mainly FSH receptors and aromatase 
(P450arom), which converts androgens to estrogens, are expressed [61]. 
 
In the preovulatory follicle shortly before ovulation, both the granulosa and theca 
cells are stratified in a distinct manner [61]: (1) Cumulus granulosa cells, which lack 
steroidogenic enzymes and express low levels of LH receptors, surround the mature 
oocyte and are extruded with the oocyte at ovulation. (2) The remaining granulosa cells 
in the follicle (the layers between basement membrane and the antrum filled with steroid 
rich follicular fluid) are named membrana granulosa, and they have high levels of LH 
receptors and steroidogenic enzymes to produce progesterone from cholesterol and 
estrogens from androgens. However, the granulosa cells that abut the basement 
membrane seem to be steroidogenically and metabolically more active than those close 
to the antral cavity.  (3) Theca-interstitial cells are identified as theca interna, the stromal 
cell layer adjacent to the basal lamina, and theca externa, a less defined layer of stromal 
cells that make up the outermost layer of the follicle. Unlike granulosa cells, the theca 
compartment is highly vascularized [59]. In the atretic follicles, both granulosa and theca 
cells disappear; however, theca cells may persist and remain in the ovarian stroma as 
nests of secondary interstitial cells for a while. These cells retain the ultrastructural 
characteristics of theca cells and continue to respond to LH by secreting steroid hormones 
[68].   
 
 10
Following ovulation with the release of the oocyte-cumulus complex, the remaining theca 
and granulosa cells undergo structural and genomic transformation to become a 
progesterone-producing endocrine gland, the corpus luteum [69]. Some of the major 
alterations during luteinization of granulosa and theca cells include: (1) increased 
expression of key proteins involved in the uptake, synthesis and transport of cholesterol, 
and in the processing of cholesterol to progesterone, androgens and estrogens, (2) 
changed expression of  various receptors that allow luteal cells to respond to a new set of 
hormones, such as the upregulation of prolactin receptors, silencing of FSH receptors, 
and a shift to the predominant expression of  ERα from ERβ  (reviewed in [69]).  The 
formation of the corpus luteum also involves the breakdown of the follicular basal 
membrane which allows migration of endothelial cells, fibroblasts and theca cells into the 
previously avascular granulosa cells [69].  
 
Once luteinization takes place, granulosa and theca cells undergo extensive hypertrophy, 
and these cells differentiate into large and small steroidogenic luteal cells, respectively, 
with the large cells producing 2- to 40-fold more progesterone than the small cells [69]. 
In contrast to the primate corpus luteum, in rodents, small and large luteal cells are 
intermingled within the corpus luteum, and they do not appear to differentiate from the 
theca and granulosa cells, respectively. Furthermore, in rodents both cell types express 
proteins that allow cholesterol conversion into estrogens [61]. Luteal cells produce 
steroid hormones until luteolysis (luteal cells lose their steroidogenic capacity and are 
eventually resorbed) unless steroidogenesis is maintained by human chorionic 
gonadotropin (hCG) [68]. 
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Regulation of Steroidogenesis  
The secretion of ovarian steroid hormones is tightly regulated by the neuroendocrine 
system (hypothalamic-pituitary-gonadal axis) and is locally controlled by intraovarian 
factors including steroids, glycopeptides and cytokines [70]. This complex process 
involves several different signaling pathways and multiple types of cells [62]. 
Steroidogenesis in most mammals appears to mainly depend on the activation of the 
cAMP/protein kinase A (PKA) pathway by pituitary-derived LH and FSH in theca and 
granulosa cells, respectively (the so called two-cell, two-gonadotropin model). In this 
model, androgens produced by the LH-stimulated theca cells are converted to estrogens 
by the FSH-stimulated granulosa cells (figure 3) [61].  LH is also a key regulator of 
steroidogenesis in the luteal cells in humans [61]; however, in rodents, LH, prolactin and 
estradiol appears to be critical luteotrophic hormones, and the cAMP/PKA pathway is not 
the primary route utilized by luteal cells [71]. 
  
Steroidogenic cells do not store significant quantities of steroid hormones; hence, steroid 
secretion is directly related to steroid synthesis, which is regulated both acutely and 
chronically. Activation of the cAMP/PKA pathway causes a rapid increase in the delivery 
of cholesterol into the inner mitochondrial membrane where the first step(s) of 
steroidogenesis occurs. This involves activation of cholesterol esterase and carrier 
proteins (e.g, steroidogenic acute regulatory protein, StAR, see below) within minutes to 
a few hours [72].  Acute regulation of steroidogenesis involves also increasing the 
catalytic rate of steroidogenic enzymes, which is regulated by the associated electron 
transfer process [73].  Chronic stimulation of cAMP/PKA signaling, which takes several 
hours, is through the phosphorylation of a number of transcription factors in the nucleus 
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to stimulate the expression of genes involved in regulating steroidogenic enzyme levels 
[72]. Among these transcription factors, steroidogenic factor-1 (SF-1, a member of the 
orphan nuclear receptor family) appears to act as a master switch to initiate transcription 
of a series of steroidogenic genes by binding to their response elements on the 
appropriate promoter regions of the genes [61].  These genes encode key proteins 
involved in the uptake, synthesis, transport and in the processing of cholesterol in each 
cell type [61].  These proteins include: (1) StAR, P450 side-chain cleavage (P450scc) and 
3β-hydroxysteroid dehydrogenase (3β-HSD) in both theca and granulosa cells, which are 
capable of making pregnenolone and progesterone from cholesterol, (2) P450c17, which 
catalyzes androgen synthesis from pregnenolone and progesterone in theca cells, and (3) 
P450arom that converts androgens to estrogens  in granulosa cells [61].   
 
Besides transcriptional regulation of these enzymes, steroidogenic pathways are regulated 
by electron-donation and the redox state of cells [73]. Two categories of enzymes are 
involved in steroid synthesis (figure 4), including cytochrome P450 (CYP) and 
hydroxysteroid dehydrogenases (HSD). There are two types of cytochrome P450s 
according to their intracellular locations, mitochondrial type I and microsomal type II. 
P450scc (product of the CYP11A1 gene) is loosely associated with the inner 
mitochondrial membrane (cytochrome P450 type I), whereas the remaining P450s (e.g., 
P450c17 and P450arom) are anchored on the inner membrane of the endoplasmic 
reticulum (type II) [72].  Generally, cytochrome P450s function as monooxygenases 
utilizing electrons donated from reduced nicotinamide adenine dinucleotide phosphate 
(NADPH) to catalyze the hydroxylation and cleavage of substrates [72]. The HSDs, 
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which include 3β-HSD and 17β-HSD, are involved in the reduction and oxidation of 
steroid hormones. They require NAD+/NADP+ as electron acceptors, while their reduced 
forms serve as donors of reducing equivalents [74].  
 
Steroid Hormone Biosynthesis 
Transport of Cholesterol into Mitochondria 
The biosynthesis of sex steroids starts from cholesterol, which is a precursor of all 
steroids [75]. Cholesterol can be synthesized de novo from acetyl coenzyme A or 
hydrolyzed from stored cholesterol esters in most steroidogenic cells. However, the major 
mechanisms for providing cholesterol are either the endocytosis of cholesterol rich low-
density lipoprotein (LDL) via LDL receptor or the selective uptake of cholesterol esters 
from high-density lipoprotein (HDL) via scavenger receptor B1 (SRB1), with the relative 
contribution of these two types of lipoproteins varying among species [75]. Once 
liberated as free cholesterol, it is immediately utilized, or it can be stored as cholesterol 
esters in lipid droplets [75] (Fig. 2).  Because cholesterol is poorly soluble in water, it 
must be transported by carrier proteins to the inner mitochondrial membrane where 
P450scc is located to be used as a steroid hormone precursor. Among these proteins, 
StarD4, which is structurally related to the StAR, has been  proposed to play a major role 
in the cytosolic movement of free cholesterol to the outer mitochondrial membrane in 
steroidogenic cells [75]. The movement of cholesterol from the outer to inner 
mitochondrial membranes is facilitated primarily by StAR, the first rate-limiting and 
regulated step in ovarian steroid biosynthesis [75]. The crucial role of StAR in 
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steroidogenesis has been illustrated by the targeted disruption of the StAR gene, which 
results in severely impaired gonadal and adrenal steroid synthesis [76].  Peripheral-type 
benzodiazepine receptor (PBR) and hormone sensitive lipase (HSL) were also shown to 
interact with StAR to facilitate cholesterol translocation from the outer to the inner 
mitochondrial membranes through the aqueous intermembrane space [77,78] (figure 5).   
 
P450 Cholesterol Side-chain Cleavage System 
The net steroidogenic capacity of a cell is determined by the expression of mitochondrial 
P450scc, which converts cholesterol  to pregnenolone in three sequential steps, 20α-
hydroxylation, 22- hydroxylation and C20,22-bond scission, at a single active site [79].  
P450scc must receive electrons from NADPH through the intermediacy of two electron 
transfer proteins, adrenodoxin reductase (ADR, a flavoprotein) and adrenodoxin (ADN, 
an iron/sulfur protein) [80]. In this reaction, the side-chain of the substrate cholesterol 
gets cleaved off to yield pregnenolone and isocaproic aldehyde at the expense of 3 
molecules of NADPH and 3 molecules of oxygen (figure 6) [81]. 
 
P450c17 and 3β-Hydroxysteroid Dehydrogenase 
Following synthesis of pregnenolone by P450scc in the mitochondria, pregnenolone then 
moves to the endoplasmic reticulum where it is converted either to 17-
hydroxypregnenolone by P450c17 [82] or to progesterone by 3β-HSD [83]. Thus, the 
steroidogenic pathway bifurcates into a ∆5- hydroxysteroid pathway (starting with 
pregnenolone) and a ∆4- ketosteroid pathway (starting with progesterone). Although the 
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same enzymes use different substrates along these parallel pathways, both pathways 
converge to produce androstenedione (figure 4).   
 
As mentioned above, the StAR/P450scc system is rate-limiting and the quantitative 
regulator of steroidogenesis. In contrast, P450c17 is the qualitative regulator, directing 
pregnenolone toward its final metabolic pathway, which is androstenedione in the theca 
cell [61].  Androstenedione can then be converted to testosterone by 17β-HSD.  
 
Aromatase and 17β-HSD 
Local and circulating levels of estrogen are controlled by P450aromatase, the product of 
the CYP19 gene [84]. The heme protein is responsible for binding of the androgenic 
steroid substrate and catalyzing the series of reactions leading to formation of the 
phenolic A ring characteristic of estrogens [84]. Tissue-specific promoters and alternative 
splicing control expression of aromatase in multiple tissues including ovary, bone, 
adipose tissue, brain and various fetal tissues [84].  
 
17β-HSD enzymes catalyze the final step in the biosynthesis of active gonadal steroid 
hormones, estradiol and testosterone. Among the many different forms of 17β-HSDs, 3 
forms participate in the final step of biosynthesis of active steroid hormones in gonads, 
types I, III and VII [74]. The type I form is responsible for follicular phase estradiol 
production by granulosa cells and is primarily induced by FSH acting via the cAMP/PKA 
pathway, whereas following silencing of FSH action after ovulation, type VII is 
responsible for estradiol formation by the corpus luteum (review in [74]). 
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Steroid Hormone Metabolism 
The ovary produces mainly two biologically active ovarian steroids, estradiol and 
progesterone, along with less active or inactive steroid hormones such as pregnenolone 
and androstenedione [61]. Circulating levels of each of these hormones is regulated by 
the rate of ovarian secretion as well as peripheral metabolism by the liver, adipose tissue, 
skin, uterus and ovary. For example, in the ovary and uterus, progesterone can be 
'inactivated'  by its conversation to 20α-hydroxyprogesterone, which is a less active 
hormone, by 20α-hydroxysteroid dehydrogenase [85]. Another pathway for metabolism 
in rodents is by 6β- or 16α- hydroxylation of progesterone in the liver [86,87], which are 

















Figure 1.  Proposed metabolic pathway of methoxychlor catalyzed by human P450s  
 
Methoxychlor is first O-demethylated to mono-OH-M, which is then either ortho-
hydroxylated to form catechol-M or is further O-demethylated to yield bis-OH-M. The 
final product tris-OH-M is then generated from bis-OH-M via ortho-hydroxylation and 
from catechol-M by O-demethylation.  
 











Figure 2. Ovarian morphology and ultrastructure of theca and granulosa cells 
 
(A) primordial follicle; (B) primary follicle; (C) secondary follicle; (D) small antral 
follicle; (E) components of antral follicles; (F) ultrastructure of a theca cell. N, nucleus; 
M, mitochondria with vesicular christae; SEM, smooth endoplasmic reticulum; L, lipid 
vesicles containing cholesteryl esters; *, connective tissue containing collagen fibers. 
 
















Figure 3. The two-cell, two-gonadotropin concept of follicle estrogen biosynthesis 
 


















Figure 4. Steroidogenic pathway in the ovary  
 
























Figure 5. Principal features of the cellular cholesterol economy 
 
























Figure 6. Schematic overview of the CYP11A1 electron-providing chain 
 
 










Project Goals and Aims 
 
The effect of MC and its mechanism(s) of action on ovarian steroidogenesis are not 
clearly defined. This project was designed to determine whether MC is able to alter 
ovarian steroidogenesis via its proposed active metabolite HPTE. The central hypothesis 
of this work is that exposure to HPTE directly inhibits ovarian steroid biosynthesis, 
which is able to cause an imbalance in circulating progesterone and estradiol levels. It is 
well established that chemicals that cause ovarian steroid imbalance could have a 
significant effect on fertility, menstrual and estrous cycle, and timing of puberty or 
menopause. The specific aims of the project are: (1) To pinpoint the potential effect of 
HPTE on ovarian steroidogenesis, (2) To examine the possible mechanism(s) of action of 
HPTE on ovarian steroidogenesis, (3) To evaluate the potential effect of HPTE on 
ovarian luteal steroidogenesis, (4) To determine whether in vivo exposure to MC lowers 







STUDY 1: AN ACTIVE METABOLITE OF THE PESTICIDE 
METHOXYCHLOR, HPTE, REDUCES PROGESTERONE, 
ANDROGEN AND ESTRADIOL PRODUCTION BY RAT 
OVARIAN CELLS BY INHIBITING THE CHOLESTEROL 




Previous in vivo studies in female rodents demonstrated decreased progesterone 
production and no change in serum estrogen levels following exposure to methoxychlor. 
It is not established how MC exerts its effect on ovarian steroidogenesis. The current in 
vitro studies examined the effects of HPTE on androgen and progesterone production by 
cultured ovarian granulosa cells and theca interstitial cells from immature rats treated 
with 20 I.U. of pregnant mare serum gonadotropin. These studies have demonstrated that 
HPTE progressively inhibits progesterone formation by granulosa and theca interstitial 
cells and androgen formation by TI cells. These effects were observed at 50 nM HPTE, 
and the main site of action appeared to be localized at the P450 cholesterol side-chain 
cleavage step, which converts cholesterol to pregnenolone in the pathway of progesterone 
and estrogen biosynthesis. In addition, the percent decrease in progesterone production 
was greater than the decline in estradiol and androgen levels suggesting that HPTE may 
increase the ovarian estrogen/progesterone ratio. These studies also provide evidence that 
HPTE does not exert its effect on ovarian steroidogenic cells by blocking cholesterol 
transport into mitochondria or by inhibiting microsomal enzymes involved in the 
conversion of pregnenolone to estrogen. 
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1. Introduction 
Environmental or occupational exposure to endocrine-disrupting chemicals (EDCs) have 
been reported to alter the normal functioning of the endocrine system in humans and 
wildlife [1,2]. One example of an  environmental toxicant is the pesticide methoxychlor 
(MC), which is released into the environment as a result of its applications to agricultural 
crops, livestock, animal feed, stored grain, home gardens and pets [3]. In vivo, MC 
exposure alters reproductive and ovarian function in laboratory rodents. Some of the 
reported adverse effects include embryonic toxicity [4], precocious puberty [5], decreased 
fertility [6], ovarian atrophy [7-9] and a dose-dependent decline in the number of follicles 
[10] and steroid production [11]. It is generally accepted that the physiological effects of 
in vivo MC treatment are mediated mainly by the active metabolite, 2,2-bis-(p-
hydroxyphenyl)-1,1,1-trichloroethane (HPTE)  [12]. Although the conversion of MC to 
HPTE occurs primarily in the liver, there is evidence for peripheral metabolism. For 
example, the ovarian surface epithelium expresses cytochrome P450 (CYP) enzymes that 
are capable of metabolizing MC [13]. Both MC and HPTE have weak estrogenic and 
antiandrogenic activities [14-16]. However, HPTE binds with higher affinity to the 
estrogen receptor (ER) [12], and it is a more potent androgen receptor (AR) blocker than 
MC [16]. In human hepatoma cells (HepG2), HPTE acted as an estrogen receptor α 
(ERα) agonist, but it acted as an antagonist to estrogen receptor β (ERβ) and the androgen 
receptor (AR) [17]. 
 
HPTE and its parent compound MC  are reported to induce proliferation of the ovarian 
surface epithelium [18] and to inhibit progesterone secretion in cultured granulosa cells 
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(GC) [19,20].These limited studies do not address the question of how MC or HPTE 
exert their effects on ovarian steroidogenesis. However, studies on male gonads 
suggested potential mechanisms of action of HPTE on steroidogenesis [21-24]. Murono 
et al. reported that HPTE inhibited both basal and hCG-stimulated testosterone formation 
by Leydig cells in a dose-dependent manner in both neonatal and young adult rats 
[22,23]. In these studies, significant declines in testosterone were observed at about 100 
nM HPTE, and this action was associated with a direct inhibition of P450 cholesterol 
side-chain cleavage (P450scc) activity. Up to now, it is not known whether HPTE has 
any effect on steroid formation by ovarian theca cells. The current in vitro studies 
examined the effects of HPTE on androgen and progesterone production by cultured 
ovarian theca-interstitial (TI) cells and progesterone and 17β-estradiol formation by 






2. Materials and Methods 
2.1. Animals 
Immature (17-day-old) female Sprague–Dawley rats (certified virus free, Hla: (SD)CVF) 
were purchased from Hilltop Lab Animals Inc., Scottdale, PA, USA. They were housed 
in polycarbonate shoebox cages (one litter of 10–12 pups with a nursing mother per cage) 
until the age of 21 days when they were weaned. At this age, 3-4 pups were placed in a 
polycarbonate shoebox cage containing a mixture of Alpha-dri (Shepard Specialty Paper, 
Watertown, TN) and Beta Chip (virgin hardwood chips from NEPCO, Warrenburg, NY) 
as the bedding material. They were exposed to a 12 h light and 12 h dark cycle, and they 
received Purina rat chow (R-M-H 3500 with 5% fat content) and tap water ad libitum. 
Animals were maintained in an AAALAC-accredited facility in compliance with the 
Guide for the Care and Use of Laboratory Animals. All animal protocols were reviewed 
and approved by the local Animal Care and Use Committee.  
 
2.2. Reagents 
Collagenase (Sigma Blend Type L), penicillin G, streptomycin sulfate, 
deoxyribonuclease I (DNase I), 22(R)-hydroxycholesterol, 5-pregnen-3β-ol-20-one 
(pregnenolone), 4-pregnen-3,20-dione (progesterone), 4-androsten-3,17-dione 
(androstenedione), dimethylsulfoxide (DMSO), and pregnant mare serum gonadotropin 
(PMSG) were purchased from Sigma, St. Louis, MO, USA. Ecolite (liquid scintillation 
fluid) was from ICN Pharmaceuticals Inc., Costa Mesa, CA, USA. Dulbecco's Modified 
Eagle Medium (DMEM) without phenol red, F-12 nutrient mixture (F-12) without phenol 
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red, medium 199 (Med 199), phosphate-buffered saline (PBS) and N-2-
hydroxyethylpiperazine-N′-2-ethane sulfonic acid (HEPES) were from Life 
Technologies, Grand Island, NY, USA. [2,3,6,7-3H(N)]-Testosterone was from Perkin-
Elmer Life Sciences, Boston, MA, USA. Unlabeled testosterone and 17β-estradiol 
(estradiol) were from Steraloids, Wilton, NH, USA. 2,2,Bis(p-hydroxyphenyl)-1,1,1-
trichloroethane (HPTE, 99% pure) was from Cedra Corp., Austin, TX, USA. RIA kits to 
quantitate progesterone, androstenedione and estradiol were purchased from Diagnostic 
Products Corporation, Los Angeles, CA. 
 
2.3. Treatment of Animals 
Animals were 23-25 days of age at the start of treatment. Each animal received a single 
injection (s.c.) of PMSG dissolved in PBS (20 IU/0.1ml). Animals were treated between 
0800 and 1000 h each day. Approximately 48 h following PMSG injection, animals were 
sacrificed by intra-peritoneal pentobarbital injection. For each experiment, 3-4 animals 
were sacrificed to yield a single pool of cells for culture in a given study. 
 
2.4. Isolation and Incubation of Whole Follicle, Theca Interstitial and 
Granulosa Cells 
Animals were 25-27 days of age when sacrificed. The ovaries were immediately 
removed, rinsed and stripped of its bursa and fat tissue in Med 199. Using fine 
microsurgery forceps, whole follicles of ~1 mm diameter were teased out and placed in 
pairs into 24-well Costar culture plates containing 1 ml of a 1:1 mixture of DMEM/F-12 
medium and 15 mM HEPES (pH 7.4), 15 mM NaHCO3, 100 U/ml penicillin G, and 
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100 µg/ml streptomycin. Follicles were incubated with 10 µM HPTE (added on the day 
of plating) for 24 h in DMEM / F12 medium at 370C in a humidified atmosphere of 95 % 
air and 5 % CO2. Fresh HPTE (dissolved in DMSO) was prepared for each experiment.  
Granulosa cells (GC) and theca-interstitial (TI) cells were isolated by slight modifications 
of the methods described previously [26,27]. Briefly, the ovaries were harvested, rinsed, 
stripped of its bursa and fat tissue, and then punctured several times with a 26-gauge 
needle until all the antral follicles were ruptured to release GC. The medium was 
centrifuged (209 x g) for 10 min to yield GC. The final GC pellet was then resuspended 
in DMEM/F-12 medium. The residual ovarian tissue was washed twice with fresh Med 
199 and incubated for 10 min (37 0C) in 10 ml of collagenase-DNase-1 solution (0.75 
mg/ml of collagenase, 1 µg/ml of DNase-1 in Medium 199). The dissociated cells were 
discarded, and the remaining tissue was further digested with collagenase for 50 min. 
Finally, ice-cold Medium 199 was added to stop further dissociation of the residual 
tissue, and the cell suspension was centrifuged (209 x g) for 10 min to yield TI cells. The 
final pellet was then resuspended in DMEM/F-12 medium.   
 
The 3β-hydroxysteroid dehydrogenase (3β-HSD) staining revealed that 15-20 % of TI 
cells and 60-70 % of GC pellet consisted of steroidogenic cells (theca and granulosa cells 
respectively). Remaining cells are vascular , stromal, fat  etc. In addition the 3β-HSD 
staining revealed that GC stained with less intensity than TI cells. 
 
GC and TI cells (105/well) were plated into 24-well Costar culture plates in 1 ml of a 1:1 
mixture of DMEM/F-12 medium containing 15 mM HEPES (pH 7.4), 15 mM NaHCO3, 
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100 U/ml penicillin G, and 100 µg/ml streptomycin as described previously [26]. Cells 
were exposed to HPTE (0, 10, 50, and 100 nM) on the day of plating and cultured for 24 
h at 370C in a humidified atmosphere of 95 % air and 5 % CO2.  Each experiment was 
repeated at least three times. The HPTE concentrations were selected based on 
preliminary sensitivity studies, which demonstrated that cultured GC and TI became 
detached from culture plates at HPTE concentrations above 1 µM. In addition, although 
plated cells (both control and HPTE treated) were viable for more than 7 days under the 
culture conditions used, their steroid output declined after about 24 h. 
 
2.5. Measurement of Progesterone, Androstenedione and Estradiol 
Progesterone, androstenedione and estradiol were quantitated directly from the collected 
medium by radioimmunassay (RIA) as described in the manufacturer’s protocol.  
 
2.6. Measurement of Testosterone 
Testosterone released into the medium was quantitated directly by specific RIA as 








2.7. Statistical Analysis 
Data were expressed as the mean ± standard error of mean (S.E.M.) and analyzed by 
ANOVA. Differences among treatment means were determined using Student–Newman–
Keuls’ test. A P value of <0.05 was considered statistically significant.  
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3. Results 
3.1. Effect of HPTE on Progesterone, Testosterone and Estradiol Production by 
Whole Follicles 
Studies were initiated to determine whether progesterone, testosterone and estradiol 
formation by ovarian follicles was sensitive to HPTE.  As described in Methods, the 
isolated follicles were placed in pairs into each well of a 24-well culture plate in 1 ml 
medium. Follicles were cultured with 10 µM HPTE for 24 h. Statistically significant 
declines were observed in each of the measured steroids. Progesterone levels declined 
from 19.72 ± 1.91 ng/ml in control follicles to 8.15 ± 0.94 ng/ml (~41 % of control, 
Figure 1, Panel A). Testosterone levels declined from 1.02 ± 0.06 ng/ml in control 
follicles to  0.78 ± 0.06 ng/ml (~76 % of control, Figure 1, Panel B) and estradiol levels 
declined from 32.67 ± 3.99 ng/ml in control follicles to  21.77 ± 3.11 ng/ml (~67 % of 
control, Figure 1, Panel C). The percent declines in testosterone and estradiol levels in 
response to HPTE were similar, but their decrease was less than the fall in progesterone 
levels. 
 
3.2- Effect of HPTE on Progesterone, Androstenedione and Testosterone 
Formation by TI Cells 
This study was conducted to localize the site(s) within the ovarian follicle where HPTE 
inhibited steroidogenesis. PMSG-stimulated ovaries were harvested, and TI cells were 
isolated and plated. Cells were incubated with varying concentrations of HPTE (0, 10, 50 
and 100 nM) for 24 h. The progesterone level in the control wells was 19.16 ± 0.78 
ng/ml/105 cells (Figure 2, Panel A). A decline in progesterone was observed with 10 nM 
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HPTE, which declined progressively to 1.40 ± 0.29 ng/ml/105 cells (7 % of control) 
following exposure to 100 nM HPTE. Similarly, androstenedione levels declined from 
13.72 ± 1.09 ng/ml/105 cells in control cells to 5.53 ± 0.52 ng/ml/105 cells (40 % of 
control) in cells exposed to 100 nM HPTE (Figure 2, Panel B). Testosterone levels 
declined from 119.05 ± 10.06 pg/ml/105 in control cells to 36.99 ± 2.60 pg/ml/105 cells 
(31 % of control) in cells exposed to 100 nM HPTE (Figure 2, Panel C). There is no 
statistical difference between testosterone and androstenedione production with the 
highest HPTE concentration when they are compared as a percentage decline. This 
suggested that the decline in the secretion of these androgens after exposure to HPTE 
followed a similar pattern. 
 
We also evaluated whether HPTE alters progesterone production by GC. Progesterone 
levels declined from 5.03 ± 0.54 ng/ml/105 cells in control cells to 0.51 ± 0.07 ng/ml/105 
cells (10 % of control) in cells exposed to 100 nM HPTE for 24 h, indicating the adverse 
effect of HPTE on GC is similar to its effect on TI cell progesterone formation.   
 
3.3- Localizing the Effect of HPTE On Ovarian Steroidogenic Pathway 
3.3.1. Role of HPTE on the delivery of cholesterol to the inner mitochondrial membrane 
To determine whether HPTE alters the translocation of cholesterol to the inner 
mitochondrial membrane, a readily diffusible form of cholesterol, 22(R)-
hydroxycholesterol (22(OH)-cholesterol), was used. Since hydroxylated cholesterol does 
not require transporters to reach the inner mitochondrial membrane [29], supplying this 
substrate to TI cells and measuring downstream steroid hormone levels namely 
 35
progesterone and testosterone, may reveal whether HPTE affects the delivery of 
cholesterol to the inner mitochondrial membrane where P450 cholesterol side-chain 
cleavage (P450scc) activity is localized. In the presence of 10 µM 22(OH)-cholesterol), 
the progesterone level in the control group was 351.92 ± 11.47 ng/ml/105 cells (Figure 3, 
Panel A). A significant decline in the progesterone level was observed following 
exposure to 50 nM HPTE, which declined further to 121.67 ± 3.51 ng/ml/105 cells (35 % 
of control) following exposure to 100 nM HPTE. Testosterone levels declined from 
557.05 ± 56.79 pg/ml/105 cells in the control group to 263.44 ± 21.36 pg/ml/105 cells (47 
% of control, Figure 3, Panel B) in cells treated with 100 nM HPTE. These results imply 
that cholesterol transport into mitochondria was not affected by HPTE and that an 
enzymatic step(s) converting cholesterol to downstream steroid products was inhibited. 
 
3.3.2- Effect of HPTE on microsomal enzymes converting pregnenolone to testosterone in 
cultured TI cells 
To test the effect of HPTE on 3β-hydroxysteroid dehydrogenase (3β-HSD) activity, 
which converts pregnenolone to progesterone, TI cells were co-cultured with HPTE (0, 
10-100 nM) and pregnenolone (10 µM) as a substrate. Next, the formation of 
progesterone and testosterone was determined following exposure for 24 h (Figure 4). 
There was no statistically significant difference either in progesterone production (23.6 ± 
1.56 µg/ml/105 cells in control, Panel A) or testosterone production (2.28 ± 0.46 
ng/ml/105 cells in control, Panel B) by TI cells following exposure to 10-100 nM HPTE 
when 10 µM pregnenolone was provided as substrate. This suggests that 3β-HSD activity 
is not affected by HPTE.  Also, this pattern of androgen formation suggests that 17α-
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hydroxylase/C17,20-lyase (P450c17) activity, which converts progesterone to 17α-
hydroxyprogesterone and androstenedione, and 17β-hydroxysteroid dehydrogenase (17β-
HSD) activity, which converts androstenedione to testosterone, are unaffected by HPTE. 
TI cells were also co-treated with 10 µM progesterone or androstenedione (10 µM) as 
substrates and varying concentrations of HPTE (10-100 nM) to more specifically 
evaluate the effect of HPTE on P450c17 and 17β-HSD activities, respectively. The 
steroid product testosterone was quantitated following 24 h of incubation when either 
substrate was included in the culture medium. There were no statistically significant 
differences in testosterone levels between control and HPTE treated groups, suggesting 
that neither P450c17 nor 17β-HSD activity is affected by HPTE (Figures 5 and 6). 
 
3.3.3 Effect of HPTE on aromatase activity 
For antral follicles to produce estradiol, the coordination between GC and TI cells is 
required [30]. Therefore, because GC have low P450c17 activity, they are unable to 
convert progesterone to androgens, while TI cells lack aromatase activity and, therefore, 
can not synthesize estradiol from androgens (androstenedione and testosterone) [30,31]. 
For estradiol to be synthesized by antral follicles, the androgens synthesized by TI cells 
must be transferred to GC where aromatase is located.  
 
To demonstrate whether  HPTE affects P450 aromatase activity, which converts 
testosterone to estradiol, GC were cultured with testosterone (10 µM) as substrate and 
varying concentrations of HPTE (10-100 nM). There was no statistically significant 
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difference in estradiol production (149.02 ± 25.05 pg/ml/105 cells in control) by GC cells 











The current studies have demonstrated that the reported active metabolite of MC, HPTE, 
progressively inhibits progesterone formation by GC and TI cells, and androgen 
formation by TI cells from immature rats. These effects could be observed at 50 nM 
HPTE, and the main site of action appeared to be localized at the P450scc step, which 
converts cholesterol to pregnenolone in the pathway of progesterone and estrogen 
biosynthesis. In addition, the percentage decrease in progesterone production was greater 
than the declines in estradiol and androgen formation suggesting that HPTE may increase 
the estrogen/progesterone ratio. Because the inclusion of exogenous substrates with 
HPTE to cultured ovarian cells demonstrated that co-incubation with 22(OH)-cholesterol 
inhibited steroidogenesis, while the addition of other steroid substrates (pregnenolone, 
progesterone, androstenedione or testosterone) produced after the P450scc step did not, 
this suggested that the primary site of HPTE action was at the P450scc step. The results 
suggested also that neither the transport of cholesterol to the inner mitochondrial 
membrane (where P450scc is localized) nor the enzymatic steps (3β-HSD, P450c17, 17β-
HSD or aromatase) involved in the conversion of pregnenolone to androgens or 17β-
estradiol, are inhibited by HPTE. This action of HPTE does not appear to be cell specific 
since progesterone formation by both GC and TI cells were affected in the current study. 
A recent study also reported that HPTE lowered FSH-stimulated progesterone formation 
by isolated GC from immature rats [20]. Besides follicular cells, previous in vitro studies 
on isolated rat Leydig cells demonstrated that basal and hCG-stimulated testosterone 
formation are decreased by HPTE inhibition of P450scc activity. The parent compound 
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of HPTE, MC, was also shown to inhibit P450scc activity in isolated mitochondria from 
the bovine adrenal cortex [32] and progesterone formation by porcine GC [11,21].  
 
The present in vitro observations indicate that HPTE specifically inhibits the P450scc 
step in the pathway of converting cholesterol to androgens and 17β-estradiol without 
affecting the other steps in the ovarian steroidogenic pathway. This conclusion was based 
on the level and pattern of steroid products produced following the co-incubation of 
cultured GC or TI cells with HPTE and exogenously supplied 22(OH)-cholesterol or 
various steroid substrates. Because 22(OH)-cholesterol does not require steroidogenic 
acute regulatory (StAR) protein to be transported to the inner mitochondrial membrane 
[29] where P450scc is localized, these results suggest that HPTE does not block StAR 
function in translocating cholesterol to the site of P450scc activity. Our results also 
support the observations of other studies reporting that HPTE did not affect StAR 
mRNA levels, the primary transporter of cholesterol into mitochondria in GC and Leydig 
cells [20,25]. However, measuring mRNA levels reflects only the potential effects of 
HPTE on StAR levels and not actual levels. The current observations with TI cells 
confirm the results of a previous study on cultured rat Leydig cells where co-incubation 
with HPTE and the substrate 22(OH)-cholesterol resulted in the progressive decline in 
testosterone formation, while HPTE had no effect on testosterone production when 
pregnenolone, progesterone or androstenedione where added as substrates [24].  In the 
present studies, the conversion of testosterone to estradiol was not affected by 100 nM 
HPTE in GC suggesting that HPTE has no effect on aromatase activity. In contrast, 
Zachow et al reported declines in estradiol formation and P450aromatase mRNA levels 
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following exposure of rat GC to 10 µM HPTE [20]. It should be noted that the 
concentration of HPTE used in this study was three orders of magnitude higher than was 
used in the current study. 
 
Although there is general agreement that HPTE inhibits the P450scc step, the mechanism 
of action is not established. Murono et al showed that HPTE (100 nM) directly inhibited 
the catalytic activity of P450scc, and that the ER or AR were not involved [23,24]. In 
contrast, Akingbemi et al reported that the decline in testosterone formation following 
exposure to 1 µM HPTE was associated with a decline in steady state P450scc mRNA 
levels, and they suggested that the effects of HPTE were mediated through the ER 
pathway [25]. Furthermore, a recent study in cultured rat GC showed that FSH-stimulated  
mRNA levels of P450scc, 3β-HSD and P450aromatase were reduced by 10 µM HPTE 
indicating that this action may not be specific to P450scc [20]. In this study, a lower 
concentration of HPTE (1 µM) as shown to inhibit progesterone formation. Therefore, it 
is possible that higher concentrations of HPTE alters mRNA levels of multiple 
steroidogenic enzymes while lower concentrations may be more specific to  P450scc 
activity leading to decreased steroid formation. We observed an increased detachment of 
cultured GC and TI cells at HPTE concentrations of 1 µM or higher, suggesting possible 
toxicity at higher concentrations (data not shown).  
 
Our current in vitro studies and other studies indicate that HPTE directly lowers GC and 
TI progesterone production and this may contribute to the decline in serum levels that 
was reported when female rodents were exposed in vivo to MC [6,12]. It has been shown 
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in previous studies that MC causes an increase in the number of atretic antral follicles 
[7,33]. A potential consequence of follicular atresia is a decrease in serum progesterone 
levels. But, it has not been determined how MC exposure causes follicular atresia, an 
active and intrinsic process [34,35]. Gonadotropins and estradiol have been reported to 
prevent apoptosis of GC from antral follicles while androgens induce it [36,37]. 
However, the role of progesterone in inducing follicular atresia has not been ruled out. 
Progesterone receptor protein and mRNA were localized to the theca of small preantral 
and antral follicles and to GC of preovulatory follicles that had been exposed to LH/hCG 
in the sheep, monkey and rabbit ovaries [38-40]. High levels of progesterone increased 
atresia of bovine nonovulatory dominant follicles [31], whereas progesterone inhibited 
apoptosis in cultured rat GC [41]. Therefore, based on our current results with HPTE, it is 
plausible that the direct inhibition of ovarian progesterone production, or alteration of the 
delicate balance between progesterone, androgen and estrogen levels locally, may 
actually be the cause of atresia in antral follicles. 
 
In conclusion, this study suggests that the HPTE specifically inhibits the P450scc step in 
ovarian steroidogenesis, which may decrease progesterone and estradiol formation in 
PMSG-primed ovarian cells from immature rats. Furthermore, this work indicates that 
HPTE may increase the estrogen/progesterone ratio, which may adversely affect normal 
follicular development. Further studies should examine the mechanism of action of HPTE 





































































Figure 1. 1. Effect of HPTE on whole follicle progesterone, testosterone and 
estradiol formation  
Ovarian follicles of  around 1 mm in diameter were placed in pairs into each well of 24- 
well culture plate and exposed to HPTE (10 µM) for 24 h. HPTE was dissolved in 
DMSO, and all treatment groups contained 0.1 % of the vehicle as a final concentration. 
Each treatment group represents the mean ± S.E.M. of 12 pairs of follicles from a single 
experiment. (a, b), P<0.050 and P<0.001, respectively, when compared with the 















































































<0.01 and P<0.001,  respectively, when compared with the appropriate control group. 
Figure 1. 2.  Effect of HPTE on TI cell progesterone and androgen production 
 
Cells (1x105/ml) were exposed to varying concentrations of HPTE (0, 10-100 nM) at the
time of plating for 24 h.  HPTE was dissolved in DMSO, and all treatment groups 
contained 0.1 % of the vehicle as a final concentration. Each treatment group represents






























































Figure 1. 3. Effect of HPTE co-incubated with the substrate 22(OH)-cholesterol on 
I cell pro esterone and testosterone production 
) and 
nts 
<0.01 and P<0.001, respectively, when compared with the appropriate control group. 
T g
 
Cells (1x105/ml) were exposed to varying concentrations of HPTE (0, 10-100 nM
22(OH)-cholesterol (10 µM) at the time of plating for 24 h.  HPTE and 22(OH)-
cholesterol were dissolved in DMSO and ethanol, respectively.  All treatment groups 
contained 0.1 % of each vehicle as a final concentration. Each treatment group represe


























































Figure 1. 4. Effect of HPTE co-incubated w
rogesterone and testosterone production 
ith the substrate pregnenolone on TI cell 
p
 
Cells (1x105/ml) were exposed to varying concentrations of HPTE (10-100 nM) and 
pregnenolone (10 µM) at the time of plating for 24 h.  HPTE and pregnenolone were 
dissolved in DMSO and ethanol, respectively. All treatment groups contained 0.1 % of 
each vehicle as a final concentration. Each treatment group represents the mean ± S.E.M. 







































Figure 1. 5. Effect of HPTE co-incubated with the substrate progesterone on TI cell 
testosterone production 
 
Cells (1x105/ml) were exposed to varying concentrations of HPTE (10-100 nM) and 
progesterone (10 µM) at the time of plating for 24 h.  HPTE and progesterone were 
dissolved in DMSO and ethanol, respectively. All treatment groups contained 0.1 % of 
each vehicle as a final concentration. Each treatment group represents the mean ± S.E.M. 

















































Figure 1. 6. Effect of HPTE co-incubated with the substrate androstenedione on TI 
cell testosterone production 
 
Cells (1x105/ml) were exposed to varying concentrations of HPTE (10-100 nM) and 
androstenedione (10 µM) at the time of plating for 24 h.  HPTE and androstenedione 
were dissolved in DMSO and ethanol, respectively. All treatment groups contained 0.1 % 
of each vehicle as a final concentration. Each treatment group represents the mean ± 














































Figure 1. 7.   Effect of HPTE co-incubated with the exogenous testosterone as 
substrate on 17β-estradiol production by cultured GC 
 
Cells (1x105/ml) were exposed to varying concentrations of HPTE (10-100 nM) and 
testosterone (10 µM) at the time of plating for 24 h.  HPTE and testosterone were 
dissolved in DMSO and ethanol, respectively. All treatment groups contained 0.1 % of 
each vehicle as a final concentration. Each treatment group represents the mean ± S.E.M. 
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STUDY 2: THE METHOXYCHLOR METABOLITE, HPTE, 
DIRECTLY INHIBITS THE CATALYTIC ACTIVITY OF 
CHOLESTEROL SIDE-CHAIN CLEAVAGE (P450SCC) IN 







Both methoxychlor and its proposed active metabolite HPTE have weak estrogenic and 
antiandrogenic activities, and these effects are thought to be mediated through the 
estrogen receptor and androgen receptor, respectively. In the first study, we showed 
indirectly that HPTE inhibits the P450 cholesterol side-chain cleavage (P450scc) step 
resulting in decreased progesterone, androgen and estrogen production by cultured 
ovarian cells. The current studies examined the mechanism of action of HPTE on 
progesterone production by cultured ovarian cells (granulosa and theca-interstitial) from 
pregnant mare serum gonadotropin-primed immature rats. In addition, we evaluated 
whether the effects of HPTE on rat ovarian cell progesterone biosynthesis were mediated 
through the estrogen or androgen receptors. Exposure to HPTE (0, 10, 50, or 100 nM) 
alone inhibited progesterone formation and the P450scc catalytic activity in a dose-
dependent manner with significant declines starting at 50 nM. However, HPTE did not 
change mRNA levels of the P450scc system (P450scc, adrenodoxin reductase and 
adrenodoxin). Of interest, estradiol, xenoestrogens (bisphenol-A or 4-tert-octylphenol), a 
pure anti-estrogen (ICI 182,780), or anti-androgens (4-hydroxyflutamide or the 
vinclozolin metabolite M-2) had no effect on progesterone production even at 1000 nM.  
Co-treatment of HPTE with ICI 182,780 did not block the effect of HPTE on 
progesterone formation. These studies reveal that HPTE directly inhibits P450scc 
catalytic activity resulting in decreased progesterone production by cultured ovarian cells. 
This action does not appear to be mediated through the estrogen or androgen receptor 
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signaling pathways, and other chemicals exhibiting estrogenic, antiestrogenic or 




It is generally accepted that the physiological effects of in vivo MC treatment are 
mediated mainly by the active metabolite, 2,2-bis-(p-hydroxyphenyl)-1,1,1-
trichloroethane (HPTE) [1]. In female rodents, exposure to MC or HPTE caused a 
uterotropic response and the proliferation of ovarian surface epithelium through estrogen 
receptor (ER)-linked mechanisms [2-4]. Both MC and HPTE have weak estrogenic and 
antiandrogenic activities [5-7]. However, HPTE binds with higher affinity to the ER [1] 
and is a more potent androgen receptor (AR) blocker [7]. In human hepatoma cells 
(HepG2), HPTE acted as an ERα agonist; however, it was antagonistic to ERβ and AR 
[8]. Although it was generally thought that chemicals such as HPTE exert their effects 
through receptor-mediated pathways, a recent study suggested that some actions of HPTE 
on steroidogenesis may not be mediated through the ER or AR [9]. For example, Murono 
et al demonstrated that the concomitant addition of the “pure” antiestrogen, ICI, did not 
block the inhibition of testosterone formation by HPTE and the exposure to the 
antiandrogenic hydroxyflutamide or vinclozolin did not mimic the effect of HPTE on 
androgen production by cultured fetal Leydig cells from neonatal male rats [9]. 
 
Regarding the effects of MC on gonadal steroidogenesis, previous in vivo studies in 
female and male rodents demonstrated decreased serum progesterone  and androgen 
levels, respectively, following exposure to MC [10-12], and the effects of HPTE on testis 
steroidogenesis localized to the P450 cholesterol side-chain cleavage (P450scc) step in 
the pathway of androgen production from cholesterol [9,12-14]. In the first study, we 
showed that HPTE inhibited the P450scc step resulting in decreased progesterone, 
 57
androgen and estrogen production by cultured ovarian cells. It has not been established 
how HPTE alters ovarian steroid production. In the current studies, we examined the 
possible mechanism(s) of action of HPTE on progesterone production by cultured 
ovarian cells from pregnant mare serum gonadotropin (PMSG)-primed immature rats. In 
addition, we evaluated whether the effects of HPTE on rat ovarian cell progesterone 
biosynthesis were mediated through the ER or AR. 
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2. Materials and Methods 
2.1. Animals 
Immature (17-day-old) female Sprague–Dawley rats (certified virus free, Hla: (SD)CVF) 
were purchased from Hilltop Lab Animals Inc., Scottdale, PA, USA. They were housed 
in polycarbonate shoebox cages (one litter of 10–12 pups with a nursing mother per cage) 
until the age of 21 days when they were weaned. At this age, 3-4 pups were placed in a 
polycarbonate shoebox cage containing a mixture of Alpha-dri (Shephard Specialty 
Paper, Watertown, TN) and Beta Chip (virgin hardwood chips from NEPCO, 
Warrenburg, NY) as the bedding material. They were exposed to a 12 h light and 12 h 
dark cycle, and they received Teklad 2918 rat chow (with 5% fat content) and tap water 
ad libitum. Animals were maintained in an AAALAC-accredited facility in compliance 
with the Guide for the Care and Use of Laboratory Animals. All animal protocols were 
reviewed and approved by the NIOSH Animal Care and Use Committee.  
2.2. Reagents 
Collagenase (Sigma Blend Type L), penicillin G, streptomycin sulfate, 
deoxyribonuclease I (DNase I), dimethylsulfoxide (DMSO), pregnant mare serum 
gonadotropin (PMSG) and neutral alumina were purchased from Sigma, St. Louis, MO, 
USA. Ecolite (liquid scintillation fluid) was from ICN Pharmaceuticals Inc., Costa Mesa, 
CA, USA. Chloroform was from Fisher Scientific, Pittsburgh, PA, USA. Dulbecco's 
Modified Eagle Medium (DMEM) without phenol red, F-12 nutrient mixture (F-12) 
without phenol red, medium 199 (Med 199), phosphate buffered saline (PBS) and N-2-
hydroxyethylpiperazine-N′-2-ethane sulfonic acid (HEPES) were from Life 
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Technologies, Grand Island, NY, USA. [2,3,6,7-3H(N)]-Testosterone (specific activity 
100 Ci/mmol), 25-[26,27-3H]-hydroxycholesterol (specific  activity 80 Ci/mmol), and 
14C-isocaproic acid were from Perkin-Elmer Life Sciences, Boston, MA, USA. 2,2,Bis(p-
hydroxyphenyl)-1,1,1-trichloroethane (HPTE, 99% pure) was from Cedra Corp., Austin, 
TX, USA. 17β-estradiol (estradiol) was from Steraloids, Wilton, NH, USA. 4, 4’-
Isopropylidenediphenol (bisphenol A) and 4-tert-octylphenol (octylphenol) were from 
Aldrich Chem. Co., Milwaukee, WI. 3′:5′-Dichloro-2-hydroxy-2-methylbut-3-enanilide 
(M-2, a metabolite of the fungicide vinclozolin with antiandrogenic properties) was a gift 
from the EPA/NHEERL, Research Triangle Park, NC, USA, through Dr. William Kelce, 
Pharmacia Corp., Kalamazoo, MI, USA. 4-Hydroxyflutamide (flutamide) was a gift from 
Schering-Plough Research Corp., Kenilworth, NJ, USA. ICI 182,780 (ICI) was a gift 
from Dr. A.E. Wakeling, Zeneca Pharmaceuticals, Cheshire, UK.  
 
2.3. Treatment of Animals 
Animals were 23-25 days of age at the start of treatment. Each animal received a single 
injection (s.c.) of PMSG dissolved in PBS (20 IU/0.1ml). Animals were treated between 
0800 and 1000 h each day. Approximately 48 h following exposure to PMSG, animals 
were sacrificed by intra-peritoneal pentobarbital injection (~200 mg/kg).  
2.4. Isolation and Culture of Theca-Interstitial and Granulosa Cells 
Granulosa cells (GC) and theca-interstitial (TI) cells were isolated by slight modifications 
of methods described previously [15,16]. Briefly, the ovaries were harvested, stripped of 
bursa and fat tissue and then punctured several times with a 26-gauge needle until all the 
antral follicles were ruptured to release GC. The medium containing GC was centrifuged 
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(209 x g) for 10 min to yield GC. The final GC pellet was then resuspended in DMEM/F-
12 medium. The residual ovarian tissue was washed twice with fresh medium, and 
incubated in a rotary shaker bath for 10 min (37 0 C) in 10 ml of collagenase-DNase-1 
solution (0.75 mg/ml of collagenase, 1 µg/ml of DNase-1 in Medium 199). The 
dissociated cells were discarded to remove the residual GC, and the remaining tissue was 
further digested with collagenase for an additional 50 min. Finally, ice-cold Medium 199 
was added to stop further dissociation of the residual tissue, and the cell suspension was 
centrifuged (209 x g) for 10 min to yield TI cells. The final  pellet was then resuspended 
in DMEM/F-12 medium.  
 
GC and TI cells (105/well) were plated into 24-well Costar culture plates in 1 ml of a 1:1 
mixture of DMEM/F-12 medium containing 15 mM HEPES (pH 7.4), 15 mM NaHCO3, 
100 U/ml penicillin G and 100 µg/ml streptomycin as described previously [15]. Cells 
were exposed to concentrations of 0, 10, 50 or 100 nM HPTE on the day of plating and 
cultured for 24 h in DMEM / F12 medium at 370 C in a humidified atmosphere of 95 % 
air and 5 % CO2.  The HPTE concentrations were chosen based on preliminary studies 
conducted to determine the sensitivity of cultured GC and TI to the chemical. 
Furthermore, cultured GC and TI cells became detached from culture plates at HPTE 
concentrations above 1 µM. In addition, although plated cells survived more than 7 days 
under the culture conditions used, their steroid output declined after about 24 h. 
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2.5. Measurement of Progesterone 
Progesterone was quantitated directly from the collected medium by radioimmunassay 




2.6. Measurement of P450 Cholesterol Side-Chain Cleavage Activity 
P450scc activity of intact TI cells and GC was determined by measuring the conversion 
of 25-[26,27-3H]-hydroxycholesterol to pregnenolone and 3H-labeled side-chain by 
utilizing a previously described procedure [17] with slight modifications [13]. In brief, 
isolated TI cells (2 x 105 /0.5 ml medium) or GC (5 x 105 /0.5 ml medium) were plated 
into 24-well culture plates. Varying concentrations of HPTE (0, 10, 50, or 100 nM) were 
added at the time of plating, and after exposure for 8 h, 25-[26,27-3H]-hydroxycholesterol 
(0.5 µCi,  5 µM ) was added to each well. The cells were incubated for an additional 16 h 
at 37 o C in an atmosphere of 95% air and 5% CO2. Reactions were stopped by adding 
50 µl of 1N NaOH to each well. The contents of each well were transferred to 7 ml 
borosilicate glass vials, and each well was washed with 1.05 ml PBS. The PBS washes 
were transferred to the vials containing the corresponding incubation media, and the 
contents were extracted with 4 ml of chloroform. After separation of the two phases, 
0.8 ml of the upper aqueous phase containing the water-soluble 3H-labeled side-chain 
was removed and placed in a 5 ml borosilicate glass culture tube containing 0.25 g 
neutral alumina, which adsorbs any contaminating substrate. The lower organic phase 
contains unmetabolized 3H-labeled substrate and unlabeled steroid product(s) (e.g., 
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pregnenolone). The aqueous phase and the neutral alumina were mixed, and the tubes 
were centrifuged (~ 1640 x g) for 20 min to settle the neutral alumina. An aliquot of the 
aqueous phase was removed and counted using Ecolite as the scintillation fluid. 
2.7. Quantitation of mRNAs By Real–Time RT-PCR (Reverse-Transcription 
Polymerase Chain Reaction)  
The mRNA levels were measured using primer sets designed using the Universal Probe 
Library Assay Design Center (http://www.roche-applied-
science.com/sis/rtpcr/upl/adc.jsp) and synthesized by Operon (Huntsville, AL) and 
performed by the ABI 7500 Sequence Detector (PE Applied Biosystems, Foster City, 
CA). Total RNA was isolated using RNAqueous-4PCR kits (Ambion, Austin, TX) from 
TI cells ( 3 million) cultured in the absence or presence of 100 nM HPTE. The DNAse I-
treated RNA (0.5-1 µg) was reverse transcribed, using Superscript II (Life Invitrogen, 
Gaithersburg, MD). The cDNA generated was diluted 1:100, and 7.25 µl was used to 
conduct the PCR reaction according to the real-time PCR kit instructions. The 
comparative CT (threshold cycle) method was used to calculate the relative 
concentrations (User Bulletin 2, ABI PRISM 7700 sequence detector, PE Applied 
Biosystems, Foster City, CA). Briefly, the method involves obtaining the CT values for 
the genes of P40scc (CYP11A1), steroidogenic acute regulatory protein (StAR), 
adrenodoxin (ADN) and adrenodoxin reductase (ADR), normalizing to a housekeeping 
gene (glyceraldehyde-3-phosphate dehydrogenase (GAPDH in the present case), and 
deriving the fold increase compared to the control, unstimulated cells (Table 2.1). 
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2.8. Statistical Analysis 
Data were expressed as the mean ± standard error of mean (S.E.M.) and analyzed by 
ANOVA. Differences among treatment means were determined using Student–Newman–
Keuls’ test. A P value of <0.05 was considered statistically significant.  
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3. Results 
3.1. Effect of HPTE on Progesterone Production  
Because the previous in vitro study on rat TI cells and GC demonstrated that the P450scc 
step in the pathway of cholesterol conversion to progesterone and estrogen production 
was inhibited by exposure to HPTE (study 1), the current studies evaluated whether in 
vitro exposure to HPTE would directly alter P450scc catalytic activity.  
 
To confirm that HPTE inhibits progesterone production, TI cells or GC were exposed to 
HPTE (0,10, 50, 100 or 500 nM) alone for 24 h. Progesterone levels declined 
progressively from 28.21 ± 2.50 ng/ml/105 cells in the control group to 2.51 ± 0.22 
ng/ml/105 cells (9 % of control) in TI cells treated with 100 nM HPTE. Similarly, GC 
production of progesterone decreased progressively from 11.42 ± 1.14 ng/ml/105 cells in 
the control group to 3.21 ± 0.32 ng/ml/105 cells (28 % of control) in cells treated with 100 
nM HPTE (Figure 2.1).  
 
3.2 Effect of HPTE on P450scc Activity of TI Cell or GC 
To demonstrate the direct effect of HPTE on P450scc activity, TI cells or GC were 
exposed to HPTE (0, 10, 50 or 100 nM) and 25-[26,27-3H]-hydroxycholesterol (0.5 µCi, 
5 µM) as described in the methods to quantitate the release of 3H-labeled side-chain into 
the medium.  Control TI cells released 14.48 ± 1.13 ng/16 h/105 cells. A significant 
decline in TI cell P450scc activity was observed following exposure to 50 nM HPTE, 
which decline further to 24% of control in the cells exposure to 500 nM HPTE (Figure 
2.2). There was no measurable decline in the P450scc activity of GC following exposure 
 65
to 10-500 nM HPTE. Possibly, this was due to the much lower P450scc activity and 
reduced sensitivity of the assay in GC. There was about a 21-fold difference between 
P450scc activities of TI cells (14.48 ± 1.13 ng/16 h/105 cells in control) and GC (0.64 ± 
0.06 ng/16 h/105 cells in control, Figure 2.2).  
 
3.3 Effect of HPTE on P450scc Gene Expression 
P450scc must receive electrons from NADPH through the intermediacy of two electron 
transfer proteins, adrenodoxin reductase (ADR, a flavoprotein) and adrenodoxin (ADN, a 
iron/sulfur protein) [19] to complete the side-chain cleavage of cholesterol. In addition, a 
mitochondrial membrane protein, steroidogenic acute regulatory protein, (StAR), is 
involved in delivering cholesterol from the outer to inner mitochondrial membrane where 
P450scc  is localized [19]. To evaluate whether HPTE alters mRNA levels of  the 
P450scc system and/or StAR, TI cells were exposed to HPTE (0 or 100 nM) for 24 h, and 
the mRNA levels for each protein were measured. There was no statistically significant 
change in the mRNA levels of P450scc, ADN, ADR or StAR. Glyceraldehyde 3-
phosphate dehydrogenase (GAPD4) was used as the reference standard (Figure 2.3).  
 
3.4 Effect of Estradiol or the Xenoestrogens, Bisphenol-A or Octylphenol, on 
Progesterone Formation 
Because HPTE binds to the ER and acts as an ERα agonist [8], studies were conducted to 
determine whether HPTE inhibition of progesterone formation is mediated through the 
ER pathway. TI cells or GC were exposed to varying concentrations of 17β-estradiol or 
the weak estrogen agonists, bisphenol-A (constituent in the manufacture of polycarbonate 
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plastics or epoxy resins) or 4-tert-octylphenol (a surfactant additive) for 24 h. There was 
no change in progesterone production by TI cells or GC following exposure to 10-1000 
nM 17β-estradiol (24.26 ± 0.88 ng/ml/105 cells and 13.64 ± 1.17 ng/ml/105 cells in 
control TI and GC, respectively, Figure 2.4, Panel A). Following exposure to 10-1000 
nM bisphenol-A, progesterone production in TI cells increased from 26.31 ± 1.62 
ng/ml/105 cells, in the control group to 31.84 ± 1.62 and 30.97 ± 1.56 ng/ml/105 cells in 
cells exposed to 50 or 100 nM bisphenol-A, respectively, however; at the highest 
concentration of bisphenol-A, TI cell progesterone production was no different than 
control (Figure  2.4, Panel B). GC progesterone level in control cells was 7.52 ± 0.24 
ng/ml/105 cells and this was unaffected by exposure to bisphenol-A (Figure 2.4, Panel B). 
Exposure of TI cells to 10-1000 nM octylphenol resulted in statistically significant 
increases in progesterone levels at the 10 or 50 nM concentrations (from 25.76 ± 1.32 
ng/ml/105 cells in control cells to 31.92 ± 1.61 and 29.68 ± 1.80 ng/ml/105 cells, 
respectively, Figure 2.4, Panel C). Progesterone production of TI cells exposed to 100 or 
1000 nM octylphenol was no different than the control level. The progesterone level in 
control GC was 11.90 ± 0.38 ng/ml/105 cells, and progesterone levels were unaffected by 
exposure to 10-1000 nM octylphenol (Figure 2.4, Panel C). 
 
Over all, these studies show that native estrogen has no effect on progesterone formation 
by TI or GC and that two xenoestrogenic chemicals, bisphenol-A or octylphenol, actually 




3.5. Effect of Antiestrogen Alone or With HPTE on TI or GC Progesterone 
Production 
The following studies were conducted to determine whether the inhibitive effect of HPTE 
on TI cell or GC progesterone formation was due to its intrinsic antiestrogenic properties 
or whether its effect could be blocked by the concomitant inclusion of the “pure” 
estrogen antagonist ICI 182,780 (ICI) which binds to both ERα and ERβ [20]. 
TI cells or GC were exposed to varying concentrations of ICI (0, 10-1000 nM) alone for 
24 h. Progesterone levels in control TI cells and GC were 30.76 ± 2.52 ng/ml/105 cells 
and 9.08 ± 0.86 ng/ml/105 cells, respectively (Figure 2.5). Exposure to ICI alone had no 
effect on progesterone production in either TI cells or GC. 
 
In a follow-up study, TI cells or GC were concomitantly exposed to varying 
concentrations of HPTE (0-100 nM) and/or ICI (5 µM) for 24 h. The progesterone level 
in control TI cells was 24.13 ± 1.37 ng/ml/105 cells (Figure 2.6). Exposure to HPTE 
inhibited progesterone formation, which declined progressively to 2.24 ± 0.20 ng/ml/105 
cells (9 % of control) following exposure to 100 nM HPTE. In GC, progesterone 
production declined from 10.89 ± 1.47 ng/ml/105 cells in control cells to 1.39 ± 0.38 
ng/ml/105 cells (13% of control) following exposure to 100 nM HPTE. Thus, the 
concomitant exposure to ICI did not alter the inhibitive effects of HPTE on TI cell or GC 




3.6. Effect of Antiandrogenic Chemicals on Progesterone Formation by TI or 
GC 
To evaluate whether the inhibition of progesterone production by HPTE in ovarian cells 
was due to its antiandrogenic properties, TI cells or GC were exposed to the 
antiandrogens flutamide or the vinclozolin metabolite, M-2. Vinclozolin is a fungicide 
currently used on various fruits and vegetables. Progesterone levels in control TI and GC 
were 20.79 ± 3.11 and 19.81 ± 3.53 ng/ml/105 cells, respectively (Figure 2.7, Panel A).  
 
Exposure to flutamide alone (10-1000 nM, Figure 2.7, Panel A) had no effect on 
progesterone formation. Similarly, exposure to M-2 alone (10-1000 nM) had no effect on 
progesterone production by TI cells or GC (Figure 2.7, Panel B). Collectively, these 
results suggest that the inhibition of progesterone formation in TI cells or GC by HPTE is 




Data obtained in this study indicate that the active metabolite of MC, HPTE, directly 
inhibits the catalytic activity of P450scc resulting in decreased progesterone production 
by cultured TI cells and GC from PMSG-primed immature rats. This effect of HPTE on 
P450scc activity, which converts cholesterol to pregnenolone in the pathway of 
progesterone and estrogen biosynthesis, could be observed at 50 nM in TI cells. The 
inhibition of P450scc by HPTE suggests that this is a direct effect on the enzyme, which 
is also confirmed by unchanged mRNA levels of the three components of the P450scc 
system (P450scc, ADR and ADN) in TI cells following exposure to 100 nM HPTE. 
Furthermore, this effect of HPTE action does not appear to be mediated through the ER 
or AR signaling pathways, the currently recognized modes of action of MC and HPTE. 
The concomitant exposure to the “pure” antiestrogen, ICI, with HPTE did not alter the 
pattern of response to HPTE, and none of various test compounds acting as an estrogen 
(17β-estradiol, bisphenol-A or octylphenol), antiestrogen (ICI) or antiandrogen 
(flutamide or the vinclozolin metabolite, M-2) when added alone to TI cells or to GC, 
mimicked the action of HPTE on progesterone production. These results suggest that the 
effect of HPTE on TI cell or GC progesterone formation are not due to its estrogenic, 
antiestrogenic or antiandrogenic qualities. 
 
Although our current studies found no effect of 100 nM HPTE on P450scc mRNA levels 
in TI cells, a recent study in cultured rat GC reported that FSH-stimulated P450scc 
mRNA levels were reduced following exposure to 10 µM HPTE for two days [21]. In 
this study, lower concentrations of HPTE (0.1 or 1 µM) were without effect [21]. In 
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addition, the mRNA levels of 3β-hydroxysteroid dehydrogenase and P450 aromatase also 
were reduced in rat GC following treatment with 10 µM HPTE [21]. These opposing 
results could be explained by differences in the concentrations of HPTE used, differences 
in exposure time or differences in culture conditions used. It should be noted that under 
the present culture conditions, there was a tendency for both TI cells and GC to detach 
from the culture wells with HPTE concentrations of over 1 µM (data not shown).  
 
Although there is general agreement that HPTE inhibits the P450scc step, the mechanism 
of action is not established. Because HPTE acts as an ERα agonist but is antagonistic to 
ERβ and AR, the receptor-linked actions of HPTE are plausible [8]. However, in the 
current study none of the estrogenic agents including 17β-estradiol itself, or the 
xenoestrogenic agents, bisphenol A or octylphenol, inhibited progesterone formation by 
TI cells or GC. In fact, bisphenol A or octylphenol modestly increased progesterone 
formation in TI cells, and when the “pure” estrogen antagonist ICI was added 
concomitantly with HPTE, it did not alter the inhibition of HPTE on progesterone 
formation. Similarly, the antiandrogenic agents, flutamide or M-2, had no effect on 
progesterone production by TI cells or GC. Collectively, these studies suggest that a 
receptor-mediated action of HPTE is unlikely. In agreement with our current results, a 
recent study also showed that exposure to estrogenic, antiestrogenic or antiandrogenic 
compounds did not alter androgen production by cultured rat Leydig cells [9], and the 
concomitant inclusion of ICI with HPTE did not block the inhibitive effects of HPTE.  In 
contrast, another study suggested that the inhibition of rat Leydig cell androgen 
production by HPTE was mediated through the ER pathway based on the observation that 
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the concomitant inclusion of ICI blocked the effects of HPTE [14]. We are unable to 
explain these differences in the results with ICI at the present time. 
 
The current observations suggest that HPTE directly inhibits P450scc catalytic activity, 
which, in turn, is responsible for a decline in progesterone formation by TI cells. 
Although the present studies did not detect a decline in P450scc activity in GC in 
response to HPTE, it is likely that this was due to the lower activity of the enzyme and 
reduced sensitivity of the assay in GC. This effect of HPTE on P450scc activity in TI 
cells is in agreement with the results of previously reported observations that the dose-
dependent decline in testosterone formation in rat Leydig cells correlated with a similar 
pattern of decline in the activity of this enzyme [9,12,13]. Although how HPTE 
specifically inhibits this step in the steroidogenic pathway is not known, a possible mode 
of HPTE action is to occupy the cholesterol-binding region of P450scc. The conversion 
of cholesterol to pregnenolone involves three distinct steps: 20α-hydroxylation, 22-
hydroxylation and the scission of the C20-22 carbon bond, and these steps occur within 
the single substrate-binding pocket of P450scc [18]. To our knowledge, there is no study 
showing that HPTE covalently binds to P450scc, but HPTE was reported to bind 
covalently to liver microsomal proteins in the presence of NADPH [22]. Moreover, the 
parent compound MC was shown to inhibit P450scc activity of bovine adrenocortical 
mitochondria by binding near to the cholesterol-binding region of this enzyme [23]. In 
this study, the inhibition by MC was diminished by inclusion of exogenous cholesterol. 
However, in study 1, the addition of cholesterol as substrate did not prevent the inhibition 
of HPTE on TI cell progesterone formation. Another possible mode of action of HPTE is 
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to alter the electron transport system. P450scc must receive electrons from NADPH 
through the intermediacy of two electron transfer proteins, adrenodoxin reductase (ADR, 
a flavoprotein) and adrenodoxin (ADN, an iron/sulfur protein) [18]. It has been reported 
that the covalent binding of MC to liver microsomal proteins involves the generation of 
several reactive oxygen species [24], which may damage enzymes involved in 
steroidogenesis. It was reported that inclusion of antioxidants had a protective effect 
against MC binding to microsomal liver proteins [22]. However, Murono et al reported 
that the concomitant exposure to increasing concentrations of two different antioxidants 
(trolox or ascorbate) did not reverse the inhibitive effects of HPTE on androgen 
production by rat Leydig cells [9,13]. 
 
A study by Akingbemi et al. reported that the inhibition of testosterone production by rat 
Leydig cells following exposure to HPTE was due to a decline in P450scc activity, which 
was the result of the decline of P450scc mRNA levels, suggesting that enzyme activity 
declined due to reduced protein synthesis [14]. However, in the current study mRNA 
levels of P450scc in TI cells were not affected by HPTE, although progesterone levels 
and P450scc activity declined. It was also reported that HPTE inhibited androgen 
formation by cultured Leydig cells as early as one hour following exposure to HPTE 
[13]. In ovarian cells, we observed the inhibition of progesterone production by HPTE 
within 3 h (unpublished observation). These reasonably rapid effects of HPTE on steroid 
production suggest that the inhibition of new protein synthesis may not explain how 
P450scc activity is suppressed in steroidogenic cells by HPTE because the half life of 
P450scc is estimated to be greater than 4 h [25]. Although the decline in progesterone 
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formation in rat ovarian cells appears to be due mainly to a direct effect of HPTE on 
P450scc activity, it is possible also that HPTE could act partly by increasing P450scc 
mRNA degradation and/or accelerating progesterone metabolism. 
 
In conclusion, this study suggests that HPTE directly inhibits P450scc catalytic activity in 
rat ovarian cells resulting in decreased progesterone production. This action of HPTE 
does not appear to be mediated through the ER or AR signaling pathways, the currently 
recognized modes of action of MC and HPTE. In addition, the inhibition of progesterone 
formation in TI cells or GC by HPTE does not appear to be due to its estrogenic, 












Table 2.1. Primer sets used for Quantitation of mRNAs by real–time RT-PCR 
 
Gene Primers Universal probe 
Sense AGC CAC ATC GCT CAG ACA C GAPDH 
(NM_002046) Antisense GCC CAA TAC GAC CAA ATC C #60 
Sense TAT TCC GCT TTG CCT TTG AG Cyp11A1  
(NM_017286.1) Antisense CAC GAT CTC CTC CAA CAT CC #9 
Sense AAG GCT GGA AGA AGG AAA GC StAR 
(ENSRNOT00000020606.3) Antisense CAC CTG GCA CCA CCT TAC TT #2 
Sense CCT GGC TTT TGG ACT AAC AAA ADN  
(D50436.1) Antisense TCC ATA GCC TTG GTC AGA CA #26 
Sense ATC CTG CTG ACC CCA CCT ADR 
(ENSRNOT00000004592.3) Antisense CCC CAG TGC AAC CTC TGT #80 
 








































Figure 2. 1. Effect of HPTE on progesterone formation by TI cells or GC 
 
Cells (1x105/ml) were exposed to varying concentrations of HPTE (0, 10-100 nM) at the 
time of plating for 24 h. HPTE was dissolved in DMSO, and all treatment groups 
contained 0.1 % of the vehicle. Each treatment group represents the mean ± S.E.M. of 
four samples from at least three separate experiments. (b, c), P<0.01 and P<0.001, 












































Figure 2. 2. Effect of HPTE on P450scc activity of TI cells or GC 
 
 
Cells (2x105 for TI or 5x105 for GC) were exposed to varying concentrations of HPTE (0, 
10-500 nM) for 24 h and 25-[26,27-3H]-hydroxycholesterol (0.5 uCi, 5 uM) for  the last 
16 h. The release of 3H-labeled side-chain (3H-4-hydroxyl-4-methyl-pentanoic acid) into 
medium was measured. HPTE was dissolved in DMSO, and all treatment groups 
contained 0.1 % of the vehicle. Each treatment group represents the mean ± S.E.M. of 
four samples from at least three separate experiments. (c), P<0.001 when compared with 

































Figure 2. 3. Effect of HPTE on mRNA levels of P450scc system and StAR 
 
TI Cells (3 million) were exposed to HPTE (0 or 100 nM) for 24 h, and the mRNA levels 
were measured immediately after isolation of TI cells. HPTE was dissolved in DMSO, 
and all treatment groups contained 0.1 % of the vehicle. Each treatment group represents 















































































Figure 2. 4. Effect of estrogen or estrogen agonists on progesterone formation by TI 
cells or GC 
 
Cells (1x105/ml) were exposed to varying concentrations of estradiol, bisphenol-A or 4-
tert-octylphenol for 24 h. Each chemical was dissolved in ethyl alcohol (100 %), and all 
treatment groups contained 0.1 % of the vehicle. Each treatment group represents the 
mean ± S.E.M. of four samples from at least three separate experiments. (a, b), P<0.050 




































Figure 2. 5. Effect of the pure estrogen receptor antagonist, ICI 182,780, alone on 
progesterone production by TI cells or GC  
 
Cells (1x105/ml) were exposed to varying concentrations of ICI for 24 h. ICI was 
dissolved in DMSO, and all treatment groups contained 0.1 % of the vehicle. Each 
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Figure 2. 6. Effect of concomitant exposure to ICI and HPTE on progesterone 
formation by TI cells or GC 
 
Cells (1x105/ml) were exposed to ICI (0 or 5 µM), and varying concentrations of HPTE 
(0, 10-100 nM) for 24 h. HPTE and ICI were dissolved in DMSO, and all treatment 
groups contained 0.1 % of the vehicle. Each treatment group represents the mean ± 
S.E.M. of four samples from at least three separate experiments. (a, c), P<0.050, and 


























































Figure 2. 7. Effect of androgen antagonists on progesterone formation by TI cells or 
GC 
 
Cells (1x105/ml) were exposed to varying concentrations of 4-hydroxyflutamide alone or 
the vinclozolin metabolite, M-2, alone for 24 h. These compounds were dissolved in 
DMSO, and all treatment groups contained 0.1 % of the vehicle. Each treatment group 
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STUDY 3: THE METHOXYCHLOR METABOLITE, HPTE, 










Our previous studies showed that HPTE specifically inhibited P450 cholesterol side-
chain cleavage (P450scc) activity resulting in decreased progesterone, androgen and 
estrogen production by cultured ovarian follicular cells. It is not known whether HPTE 
has any effect on progesterone formation by the corpus luteum. Following ovulation, 
follicular cells differentiate into non-dividing progesterone-producing luteal cells. The 
current studies examined the effect of HPTE on progesterone production by cultured 
luteal cells isolated following treatment of immature female rats with an ovulatory dose 
of pregnant mare serum gonadotropin. Luteal cells were isolated 2, 5 or 8 days following 
the estimated time of ovulation to examine whether the stage of the luteal phase affected 
its sensitivity to HPTE with respect to progesterone formation.  Cultured luteal cells were 
exposed to HPTE (0, 10, 50, 100 or 500 nM) alone for 24 h. Luteal cells isolated 2 or 5 
days post ovulation had reduced progesterone formation following exposure to 50 nM 
HPTE with progressive declines to < 12 % of control at 500 nM HPTE. Luteal cells 
isolated on day 8 post ovulation were sensitive only to the highest dose of HPTE. A 
decline in P450scc activity in response to increasing concentrations of HPTE correlated 
with the decline in progesterone formation. These studies revealed that HPTE 
progressively inhibits rat luteal cell progesterone formation at concentrations as low as 50 
nM, and that this decrease in progesterone was associated with a corresponding decline in 




Steroid hormone production by the ovary is essential for oocyte and follicle development 
as well as for the initiation and maintenance of pregnancy in mammals [1]. The ovary 
produces progestins, androgens and estrogens in a sequential manner, with the former 
serving as substrate for the subsequent steroid, and the levels secreted vary with the stage 
of follicle development [2]. The preovulatory follicle (multiple follicles in rodents) 
secrets mainly estrogens (estradiol and estrone) along with androgens 
(dehydroepiandrostenodione, androstenedione and testosterone), which reach higher 
levels shortly before ovulation, whereas the corpus luteum primarily produces 
progesterone along with estrogens [3]. Previous in vivo studies in female and male 
rodents reported decreased serum progesterone and androgen levels, respectively, 
following exposure to MC [4-6]. Studies 1 and 2 suggested that HPTE inhibited the 
catalytic activity of P450scc resulting in decreased progesterone, androgen and estrogen 
formation in follicular cells (theca-interstitial and granulosa). It has not been established 
whether HPTE has similar effects on steroid production in the corpus luteum. After 
ovulation, follicular cells differentiate into non-dividing progesterone-producing luteal 
cells [7]. Unlike follicular cells, luteal cells are insensitive to cAMP [8] and 
predominantly express ERα suggesting that the regulatory mechanisms that control their 
function may not be the same as those that control follicle cell function [9]. The current 
studies examined the effect of HPTE on progesterone production by cultured luteal cells 
from immature rats treated with an ovulatory dose of pregnant mare serum gonadotropin 
(PMSG). 
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2. Materials and Methods 
2.1. Animals 
Immature (17-day-old) female Sprague–Dawley rats (certified virus free, Hla: (SD)CVF) 
were purchased from Hilltop Lab Animals Inc., Scottdale, PA, USA. They were housed 
in polycarbonate shoebox cages (one litter of 10–12 pups with a nursing mother per cage) 
until the age of 21 days when they were weaned. At this age, 3-4 pups were placed in a 
polycarbonate shoebox cage containing a mixture of Alpha-dri (Shepherd Specialty 
Paper, Watertown, TN) and Beta Chip (virgin hardwood chips from NEPCO, 
Warrenburg, NY) as the bedding material. They were exposed to a 12 h light and 12 h 
dark cycle, and they received Teklad 2918  rat chow (with 5% fat content) and tap water 
ad libitum. Animals were maintained in an AAALAC-accredited facility in compliance 
with the Guide for the Care and Use of Laboratory Animals. All animal protocols were 
reviewed and approved by the NIOSH Animal Care and Use Committee.  
2.2. Reagents 
Collagenase (Sigma Blend Type L), penicillin G, streptomycin sulfate, 
deoxyribonuclease I (DNase I), dimethylsulfoxide (DMSO), pregnant mare serum 
gonadotropin (PMSG) and neutral alumina were purchased from Sigma, St. Louis, MO, 
USA. Ecolite (liquid scintillation fluid) was from ICN Pharmaceuticals Inc., Costa Mesa, 
CA, USA. Chloroform was from Fisher Scientific, Pittsburgh, PA, USA. Dulbecco's 
Modified Eagle Medium (DMEM) without phenol red, F-12 nutrient mixture (F-12) 
without phenol red, medium 199 (Med 199), phosphate buffered saline (PBS) and N-2-
hydroxyethylpiperazine-N′-2-ethane sulfonic acid (HEPES) were from Life 
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Technologies, Grand Island, NY, USA. 25-[26,27-3H]-Hydroxycholesterol (specific  
activity 80 Ci/mmol), and 14C-isocaproic acid were from Perkin-Elmer Life Sciences, 
Boston, MA, USA. 2,2,Bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE, 99% pure) 
was from Cedra Corp., Austin, TX, USA.  
2.3. Treatment of Animals 
Animals were 23-25 days of age at the start of treatment. Each animal received a single 
ovulatory dose of PMSG (20 IU/0.1 ml, s.c.) dissolved in PBS. Animals were treated 
between 0800 and 1000 h each day. Animals ovulate about 72 h following PMSG 
injection, and the third day after PMSG treatment was marked as post ovulation day-0. 
Following ovulation, the ruptured follicles are converted into corpora lutea, which have a 
functional life span of 10-12 days [10].   
  
2.4. Isolation and Incubation of Luteal Cells 
Luteal cells were isolated by slight modifications of previously described methods for 
theca-interstitial cells [11]. Briefly, the ovaries were harvested 2, 5 or 8 days following 
the anticipated day of ovulation. They were stripped of bursa and fat tissue, and then 
punctured several times with a 26-gauge needle until all antral follicles had been pierced 
to release granulosa cells. While the corpora lutea remained intact under these conditions. 
The ovarian tissue was washed twice with medium and incubated for 10 min (370 C) in 
10 ml of collagenase / DNase-1 solution (0.75 mg/ml of collagenase, 1 µg/ml of DNase-1 
in Medium 199). The dissociated cells were discarded, and the remaining tissue was 
further digested with collagenase for an additional 50 min to disperse the luteal tissue. 
Ice-cold Medium 199 was added to stop further dissociation, and the undigested tissue 
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was allowed to settle to the bottom of the 50 ml conical tubes and discarded. The 
supernatant containing dispersed luteal cells was aspirated and centrifuged (209 x g) for 
10 min to yield a luteal cell pellet. The final pellet was then resuspended in DMEM/F-12 
medium.  
 
Luteal cells (105/well) were plated into 24-well Costar culture plates in 1 ml of a 1:1 
mixture of DMEM/F-12 medium containing 15 mM HEPES (pH 7.4), 15 mM NaHCO3, 
100 U/ml penicillin G, and 100 µg/ml streptomycin as described previously [12]. Cells 
were exposed to concentrations of 0, 10, 50, 100 or 500 nM HPTE on the day of plating 
and cultured for 24 h in DMEM / F12 medium at 370 C in a humidified atmosphere of 95 
% air and 5 % CO2.  The HPTE concentrations, incubation period and luteal cell numbers 
per well were chosen based on preliminary studies conducted to determine the sensitivity 
of cultured luteal cells to the chemical.  
2.5. Measurement of Progesterone 
Progesterone was quantitated directly from the collected medium by radioimmunassay 
(RIA) as described in the manufacturer’s protocol (Diagnostic Products Corporation, Los 
Angeles, CA). 
 
2.6. Measurement of P450 Cholesterol Side-Chain Cleavage Activity 
P450scc activity of intact luteal cells was determined by measuring the conversion of 25-
[26,27-3H]-hydroxycholesterol to pregnenolone and 3H-labeled side-chain by utilizing a 
previously described procedure [13] with slight modifications. In brief, following 
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isolation of luteal cells (2 x 105 /0.5 ml medium), cells were plated into 24-well culture 
plates.  Varying concentrations of HPTE (0, 10, 50, 100 or 500 nM) were added at the 
time of plating, and after exposure for 8 h, 25-[26,27-3H]-hydroxycholesterol (0.5 µCi,  5 
µM ) was added to each well. The cells were incubated for an additional 16 h at 37o C in 
an atmosphere of 95% air and 5% CO2. Reactions were stopped by adding 50 µl of 1N 
NaOH to each well. The contents of each well were transferred to 7 ml borosilicate glass 
vials, and each well was washed with 1.05 ml of PBS. The PBS washes were transferred 
into the vials containing the corresponding incubation media, and the contents were 
extracted with 4 ml of chloroform. After separation of the two phases, 0.8 ml of the upper 
aqueous phase containing the water-soluble 3H-labeled side-chain was removed and 
placed in a 5 ml borosilicate glass culture tube containing 0.25 g neutral alumina, which 
adsorbs any contaminating substrate. The lower organic phase contains unmetabolized 
3H-labeled substrate and unlabeled steroid product(s) (e.g., pregnenolone). A known 
amount of 14C-isocaproic acid, was processed in separate wells in a similar manner to 
estimate recoveries. The aqueous phase and the neutral alumina were mixed, and the 
tubes were centrifuged (~ 1640 x g) for 20 min to settle the neutral alumina. An aliquot of 
the aqueous phase was removed and counted using Ecolite as the scintillation fluid. 
2.7. Statistical Analysis 
Data were expressed as the mean ± standard error of mean (S.E.M.) and analyzed by one-
way ANOVA. Differences among treatment means were determined using Student–
Newman–Keuls’ test. A P value of <0.05 was considered statistically significant.  
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3. Results 
3.1. HPTE Inhibits Progesterone Production  
Studies were initiated to determine whether progesterone production by luteal cells was 
sensitive to HPTE and whether the day of isolation following ovulation affected its 
sensitivity to HPTE.  Luteal cells were exposed to HPTE (0, 10, 50, 100 or 500 nM) 
alone for 24 h on post ovulation days 2, 5 or 8. HPTE progressively inhibited 
progesterone formation in luteal cells isolated 2 or 5 days following ovulation. Statistical 
declines were observed at 50 nM in both groups. In day-2 luteal cells, progesterone levels 
declined progressively from 206.05 ± 10.58 ng/ml/105 cells in the control group to 30.95 
± 5.33 ng/ml/105 cells (15 % of control) in cells treated with 500 nM HPTE (Figure, 3.1 
Panel A). Similarly, in luteal cells isolated on day 5 following ovulation, the production 
of progesterone decreased from 205.40 ± 54.00 ng/ml/105 cells in the control group to 
16.84 ± 2.10 ng/ml/105 cells (8 % of control) in cells treated with 500 nM HPTE (Figure 
3.1, Panel B).  In contrast, in luteal cells isolated on day 8 post ovulation, progesterone 
formation declined only following treatment with 500 nM HPTE. Progesterone levels 
declined from 253.09 ± 20.27 ng/ml/105 cells  in control cells to 127.67± 19.03 ng/ml/105 
cells (50 % of control, Figure 3.1, Panel C). 
 
3.2 HPTE Inhibits the Catalytic Activity of P450scc  
To demonstrate the direct effect of HPTE on P450scc activity, luteal cells isolated on day 
5 following ovulation were exposed to HPTE (0, 10, 50, 100 or 500 nM) and 25-[26,27-
3H]-hydroxycholesterol (0.5 µCi, 5 µM) as described in the methods section to quantitate 
the release of 3H-labeled side-chain into the medium. Control cells released 6.21 ± 1.46 
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ng/16 h/105 cells. A significant decline in luteal cell P450scc activity was observed 
following exposure to 100 nM HPTE, which decline further to 2 % of control following 
exposure to 500 nM HPTE (Figure 3.2).  
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Discussion 
Data obtained in this study indicate that the active metabolite of MC, HPTE, 
progressively inhibits progesterone formation by cultured luteal cells from PMSG-treated 
immature rats. This decline in progesterone formation following exposure to HPTE was 
associated with a corresponding progressive decline in P450scc activity, the rate-limiting 
step in the biosynthesis of progesterone, androgens and estrogens. Inhibition of 
progesterone formation could be observed at 50 nM HPTE during the early luteal phase 
(post ovulation days 2 and 5). However, in luteal cells isolated during the later luteal 
period (post ovulation day 8), progesterone formation was inhibited only by 500 nM 
HPTE, suggesting that the corpus luteum becomes less sensitive to HPTE during this 
later phase. The expected life span of the rat corpus luteum following treatment of 
immature female rats with an ovulatory dose of PMSG is 10-12 days [10]. Currently, we 
do not have an explanation for this reduced sensitivity to HPTE during the later stage of 
luteal life; however, one possibility is the sustained high levels of progesterone secreted 
by the corpus luteum, which may be protective. For example, it was shown that intra-
ovarian administration of progesterone antagonist mifepristone (RU486) inhibited luteal 
progesterone production in pregnant rats [14], and the administration of the synthetic 
progesterone, promegestone (R5020), increased progesterone formation in the cultured 
luteal cells from 19-day-pregnant rats [15].  
 
The pattern of inhibition by HPTE on progesterone formation by luteal cells isolated 
during the early post ovulation phase (post ovulation days 2 or 5) is similar to the pattern 
observed previously in follicular cells (studies 1 and 2), suggesting that the luteinization 
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of follicular cells after ovulation does not alter its sensitivity to HPTE. The corpus luteum 
expresses high levels of key proteins involved in the uptake and transport of cholesterol 
which facilitates progesterone production [7]. In fact, the current study demonstrated that 
the capacity of luteal cells to produce progesterone (> 200 ng/ml/105 cells) is more than 
10-fold higher than the capacity of theca-interstitial cells and about 40-fold higher than 
that of granulosa cells under similar culture conditions (study 1). Although luteal cells 
have this enhanced capacity to produce progesterone, exposure to 100 nM HPTE lowered 
progesterone output to <20 % of control cells in both follicular and luteal cells (isolated 
on day 5 post ovulation). This may suggest that competitive inhibition by HPTE to the 
cholesterol-binding site of P450scc is an unlikely mechanism to inhibit the enzyme as 
suggested previously in bovine adrenocortical cells [16], because higher levels of HPTE 
would be expected to be required to inhibit the enzyme and progesterone formation in 
luteal cells. In support of this observation, in the first study we observed that the addition 
of exogenous 22-hydroxycholesterol to cultured theca-interstitial cells did not block the 
inhibition of progesterone formation elicited by HPTE.  
 
The current study on rat luteal cells confirms the results of our previous studies that 
HPTE directly inhibits progesterone formation in both rat ovarian theca-interstitial and 
granulosa cells (studies 1 and 2). HPTE also has been reported to inhibit androgen 
formation in rat Leydig cells [17,18]. Similar to the studies reported in rat Leydig cells 
[18] and TI cells (study 1), the decline in androgen or progesterone formation, 
respectively, by HPTE was associated with a decline in P450scc activity in luteal cells. 
Thus, HPTE appears to reduce steroid formation in different steroid-producing cells at a 
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common steroidogenic step. Previous studies in rat Leydig cells [19] and in rat ovarian 
GC [20] suggested that the decline in P450scc activity was due to the inhibition of new 
protein synthesis for the enzyme; however, in rat ovarian TI cells, HPTE had no effect on 
P450scc mRNA levels. We propose that similar to TI cells, MC / HPTE inhibits 
progesterone formation in rat luteal cells by directly inhibiting P450scc catalytic activity. 
  
In conclusion, this study demonstrates for the first time that HPTE directly inhibits 
progesterone formation by rat ovarian luteal cells isolated from PMSG-treated immature 
rats. This decline in progesterone formation was associated with the inhibition in luteal 












































































Figure 3. 1. Effect of HPTE on progesterone formation by luteal cells isolated on 
post ovulation days 2, 5 or 8 
Cells (1x105/ml) were exposed to varying concentrations of HPTE (0, 10-500 nM) at the 
time of plating for 24 h. Luteal cells were isolated on post ovulation day 2 (Panel A), day 
5 (Panel B) or day 8 (Panel C). HPTE was dissolved in DMSO, and all treatment groups 
contained 0.1 % of the vehicle. Each treatment group represents the mean ± S.E.M. of 
four samples from at least three separate experiments. (b, c), P<0.01 and P<0.001 


































Figure 3. 2. Effect of HPTE on P450scc activity of rat luteal cells  
 
Luteal cells (2 x 105/0.5 ml), isolated on day 5 after ovulation, were exposed to varying 
concentrations of HPTE (0, 10-500 nM) for 24 h and 25-[26,27-3H]-hydroxycholesterol 
(0.5 µCi, 5 µM) for the last 16 h. The release of 3H-labeled side-chain (3H-4-hydroxyl-4-
methyl-pentanoic acid) into medium was measured. HPTE was dissolved in DMSO, and 
all treatment groups contained 0.1 % of the vehicle. Each treatment group represents the 
mean ± S.E.M. of four samples from at least three separate experiments. (b, c), P<0.01 
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STUDY 4: THE EFFECTS OF IN VIVO EXPOSURE OF 
METHOXYCHLOR TO IMMATURE RATS ON SERUM 
PROGESTERONE AND ESTRADIOL LEVELS AND THE 
EX VIVO FORMATION OF PROGESTERONE BY THECA-






In the first three in vitro studies, the exposure of isolated ovarian cells (theca, granulosa 
and luteal) with the proposed active metabolite of MC, HPTE, resulted in decreased 
progesterone and estradiol production, suggesting direct ovarian effects. The current 
study was initiated to examine whether the daily in vivo exposure of immature female rats 
to methoxychlor (0, 20-200 mg/kg) for a short duration (5-6 days), alone or under 
conditions where the maturation of ovarian follicles was accelerated by treating animals 
with pregnant mare serum gonadotropin (PMSG) during the last 2 days of exposure to 
methoxychlor, altered serum progesterone or estradiol levels or the ex vivo production of 
progesterone by theca-interstitial cells.  In animals not treated with PMSG, serum 
progesterone levels declined progressively with the dose of methoxychlor starting at the 
100 mg/kg dose; however, under these conditions, serum estradiol levels were below the 
level of detection. In those studies where animals were exposed to methoxychlor and to 
PMSG during the last 2 days of methoxychlor exposure, serum progesterone levels of 
methoxychlor-exposed animals were no different than control levels; however, serum 
estradiol level declined modestly in animals exposed to methoxychlor. In ex vivo studies 
on ovarian cells obtained from animals exposed in vivo to methoxychlor but without 
PMSG, progesterone production under basal conditions of cells exposed to methoxychlor 
was no different than control; however, when cells were exposed to hCG, cells exposed 
in vivo to methoxychlor actually produced more progesterone than control cells. In ex 
vivo studies on ovarian cells obtained from animals exposed in vivo to methoxychlor but 
also to PMSG during the last 2 days of methoxychlor exposure, ovarian cells incubated 
under basal conditions and exposed to methoxychlor produced more progesterone than 
 103
control cells. These studies demonstrate that the pattern of circulating progesterone or 
estradiol levels and ovarian cell production of steroids in response to in vivo exposure to 
methoxychlor is influenced by the maturational status of ovarian follicles and to possible 
differences in how female rats metabolize methoxychlor and /or major ovarian steroids. 
Further, these results suggest that the pattern of active steroids secreted ex vivo by 









The ovary produces mainly two biologically active ovarian steroids, estradiol and 
progesterone along with less active or inactive steroid hormones such as pregnenolone 
and androstenedione [1]. Circulating levels of each of these hormones is regulated by the 
rate of ovarian secretion as well as peripheral metabolism by the liver, adipose tissue, 
skin, uterus and ovary [2-4]. The first three in vitro studies have suggested that MC 
directly targets ovarian steroidogenesis, whereby progesterone formation by ovarian cells 
was inhibited by the proposed active metabolite HPTE. In the very first study, HPTE 
inhibited progesterone, androgen and estradiol production by the whole follicle but the 
percent decrease in progesterone production was greater than the decline in estradiol and 
androgen levels. Previous in vivo studies in female and male rodents demonstrated 
decreased serum progesterone and androgen levels, respectively, following exposure to 
MC [5-7]. In male rats, the decline in serum androgen levels was correlated with a 
decrease in Leydig cell P450 cholesterol side-chain cleavage (P450scc) activity, which 
converts cholesterol to pregnenolone in the pathway of androgen biosynthesis, and  the ex 
vivo decline in testosterone formation by Leydig cells from the  MC-exposed animals [7]. 
However,  the decline in serum progesterone was not supported by ex vivo ovarian tissue 
steroid output from the same animals exposed to MC suggesting that peripheral 
metabolism of progesterone may influence serum steroid patterns [6]. In the same study, 
the administration of MC had no effect on serum estradiol levels; however, the ex vivo 
incubation  of ovarian tissue isolated a day following treatment and incubated without or 
with hCG, demonstrated a reduction in estradiol production by cells exposed in vivo to 
MC [6]. In young mature female mice, the daily i.p. administration of MC for 20 days 
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had no effect on serum estradiol levels although atresia of antral follicles increased in 
relation to the dose of MC [8]. Thus, MC action on circulating ovarian steroid levels has 
not been clearly defined. The current studies evaluated whether the daily in vivo 
administration of methoxychlor (0, 20-200 mg/kg body weight) for a short duration (5 or 
6 days) by gavage altered serum progesterone and estradiol levels and ex vivo theca-
interstitial (TI) cell progesterone formation in immature female rats treated without or 





2. Materials and Methods 
2.1. Animals 
Immature (17-day-old) female Sprague–Dawley rats (certified virus free, Hla: (SD)CVF) 
were purchased from Hilltop Lab Animals Inc., Scottdale, PA, USA. They were housed 
in polycarbonate shoebox cages (one litter of 10–12 pups with a nursing mother per cage) 
until the age of 20 days when they were weaned. At this age, 2-3 pups were placed in a 
polycarbonate shoebox cage containing a mixture of Alpha-dri (Shepherd Specialty 
Paper, Watertown, TN) and Beta Chip (virgin hardwood chips from NEPCO, 
Warrenburg, NY) as the bedding material. They were exposed to a 12 h light and 12 h 
dark cycle, and they received Teklad 2918  rat chow (with 5% fat content) and tap water 
ad libitum. Animals were maintained in an AAALAC-accredited facility in compliance 
with the Guide for the Care and Use of Laboratory Animals. All animal protocols were 
reviewed and approved by the NIOSH Animal Care and Use Committee.  
2.2. Reagents 
Collagenase (Sigma Blend Type L), penicillin G, streptomycin sulfate, 
deoxyribonuclease I (DNase I), dimethylsulfoxide (DMSO), pregnant mare serum 
gonadotropin (PMSG) and corn oil were purchased from Sigma, St. Louis, MO, USA. 
Human chorionic gonadotropin (hCG, CR-127, 14900 IU/mg) was a gift from NIDDKD, 
Bethesda, MD. Dulbecco's Modified Eagle Medium (DMEM) without phenol red, F-12 
nutrient mixture (F-12) without phenol red, medium 199 (Med 199), phosphate buffered 
saline (PBS) and N-2-hydroxyethylpiperazine-N′-2-ethane sulfonic acid (HEPES) were 
 107
from Life Technologies, Grand Island, NY, USA. Methoxychlor (MC) was from MP 
Biomedicals, Solon, OH, USA.  
2.3. Treatment of Animals 
Animals were 21-24 days of age at the start of treatment. They received 0, 20, 100 or 200 
mg/kg body weight of MC dissolved in corn oil once daily by gavage. In those 
experiments where animals were treated with PMSG to stimulate the growth of follicles, 
they received a single injection (s.c.) of PMSG dissolved in PBS (20 IU/0.1ml) 
approximately 48 h prior to sacrifice. Under these conditions follicles (generally 7-9 per 
ovary in the current experiments) ovulate about 3 days after treatment with PMSG, and 2 
days after treatment with PMSG when animals were sacrificed, follicles would consist of 
antral, preovulatory follicles. Fresh MC was prepared every other day during this 
treatment period. This dose range was selected because they have been used in previous 
studies and demonstrated to affect steroid production in female and male rats [6,7].  The 
volume of corn oil alone or MC in corn oil that each animal received was equivalent to 5 
ml/kg body weight during this treatment period. Body weights were taken daily to adjust 
the volume or dose of corn oil or MC administered for any weight gains, and all 
treatment groups gained weight during this treatment period, and there was no 
statistically significant body weight change among dose groups. Animals were treated 
between 0800 and 1000 h each day. Approximately 24 h following the last MC exposure, 
animals were sacrificed by immersing each animal in a container saturated with CO2.  
Trunk blood was collected. After sitting at room temperature for ~30 min, blood samples 
were centrifuged to obtain serum. Ovaries were collected for ex vivo studies. To reach the 
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adequate cell yield per group, ovaries from 2-3 animals as well as the blood samples from 
the same animals were pooled.  
2.4. Isolation and Incubation of Theca-Interstitial Cells 
Theca-interstitial (TI) cells was isolated by slight modifications of the methods described 
previously [9]. Briefly, the ovaries were harvested, stripped of bursa and fat tissue and 
then punctured several times with a 26-gauge needle until all the antral follicles were 
ruptured to release granulosa cells. The residual ovarian tissue was washed twice with 
fresh medium and incubated in a rotary shaker bath for 10 min (370 C) in 10 ml of 
collagenase / DNase-1 solution (0.75 mg/ml of collagenase, 1 µg/ml of DNase-1 in 
Medium 199). The dissociated cells were discarded to remove the residual granulosa 
cells, and the remaining tissue was further digested with collagenase for an additional 50 
min. Finally, ice-cold Medium 199 was added to stop further dissociation of the residual 
tissue, and the cell suspension was centrifuged (209 x g) for 10 min to yield TI cells. The 
final pellet was then resuspended in DMEM/F-12 medium. TI cells (105/well) were 
plated into 24-well Costar culture plates in 1 ml of a 1:1 mixture of DMEM/F-12 medium 
containing 15 mM HEPES (pH 7.4), 15 mM NaHCO3, 100 U/ml penicillin G and 
100 µg/ml streptomycin as described previously [10]. Cells were cultured for 24 h in 
DMEM / F12 medium at 370 C in a humidified atmosphere of 95 % air and 5 % CO2.   
2.5. Measurement of Progesterone and Estradiol 
Progesterone and estradiol were quantitated directly from the collected medium by 
radioimmunassay (RIA) as described in the manufacturer’s protocol (Diagnostic Products 
Corp., Los Angeles, CA).  
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2.6. Statistical Analysis 
Data were expressed as the mean ± standard error of mean (S.E.M.) and analyzed by one-
way ANOVA. Differences among treatment means were determined using Student–





3.1. Serum Progesterone and Estradiol Levels  
To evaluate whether MC affects serum progesterone or estradiol levels, 21-24 day old 
animals were exposed once daily to 0, 20, 100 or 200 mg/kg of MC for 6 consecutive 
days.  Serum progesterone levels declined progressively from 3.32 ± 0.64 ng/ml in 
control animals to 1.42 ± 0.21 ng/ml in animals exposed to 100 mg/kg MC (~43 % of 
control) and decline further to 1.07 ± 0.26 ng/ml (~30 % of control) in animals treated 
with 200 mg/kg of MC (Figure 4.1). Serum estradiol levels were below sensitivity of the 
RIA under these conditions and could not be quantitated.  
 
To examine whether MC affects serum progesterone and estradiol levels in PMSG-
primed animals, 21-24 day-old animals were exposed once daily to 0 or 200 mg/kg MC 
for 6 consecutive days, and each animal received a single injection of PMSG (20 IU/0.1 
ml, s.c.) ~ 48 h prior to the time blood collection to stimulate the growth of follicles. 
Serum progesterone levels were unaffected in the animals exposed to MC (4.97 ± 0.58 
ng/ml in control animals, Figure 4.2, Panel A). Because ovarian follicle maturation was 
enhanced by  treatment with PMSG, serum estradiol could be quantified and declined 
from 299.98 ± 22.25 pg/ml in control animals to 214.05 ± 20.49 pg/ml (~72 % of control) 





3.2. Ex vivo Theca-Interstitial Cell Progesterone Formation 
Because previous in vitro studies demonstrated that progesterone formation by cultured 
theca-interstitial (TI) cells was inhibited by exposure to HPTE (studies 1 and 2), the 
current studies evaluated whether the in vivo exposure of immature female rats to the 
parent compound, MC, without or with PMSG (a single injection ~ 48 h prior to animal 
sacrifice to stimulate the growth of follicles), would inhibit ex vivo progesterone 
formation by TI cells.  
 
TI cells isolated from control animals produced 1.82 ± 0.28 ng/ml/105 cells under basal 
conditions (Figure 4.3, Panel A). Exposing animals to 100 mg/kg of MC for 5 
consecutive days had no effect on TI cell progesterone formation under basal conditions.  
However, when TI cells, isolated from animals treated with 100 mg/kg MC for 5 
consecutive days without PMSG, were cultured in the presence of 10 mIU/ml hCG, 
control cells produced 12.53 ± 1.28 ng progesterone /ml/105 cells (~ 7 fold higher than 
cells cultured under basal conditions), and TI cells isolated from animals exposed to 100 
mg/kg MC produced even more progesterone (26.44 ± 1.08 ng/ml/105 cells; 211 % of 
control; Figure 4.3, Panel B). 
Culture of TI cells isolated from animals exposed in vivo to MC (0 or 200 mg/kg) for 6 
consecutive days, with the addition of PMSG during the last 2 days of exposure, is 
presented in Figure 4.3, Panel C. These cells were not exposed to hCG because they were 
exposed to PMSG in vivo. TI cells from control animals produced 25.30 ± 2.09 ng/ml/105 
cells of progesterone over 24 h. Progesterone levels increased to 38.44 ± 3.27 ng/ml/105 




The current studies have demonstrated that the in vivo exposure of MC (0, 20-200 mg/kg) 
to immature female rats for a short duration (5-6 consecutive days) progressively lowers 
serum progesterone levels. This decline could be observed at a dose of 100 mg/kg body 
weight, which declined further at the 200 mg/kg dose. In contrast, when immature female 
rats were exposed to MC (200 mg/kg ) for 5 consecutive days and the maturation of 
ovarian follicles accelerated by treating animals with PMSG during the last 2 days of MC 
exposure, serum progesterone levels were unaltered, although serum estrogen levels 
declined to ~ 72 % of control. Furthermore, when TI cells, isolated from immature 
female rats previously exposed in vivo to corn oil or MC (100 mg/kg) alone for 5 
consecutive days, were cultured for 24 h, progesterone levels were no different than 
control in TI cells exposed in vivo to MC and cultured without hCG.  However, when 
these cells were cultured in the presence of 10 mIU/ml hCG, TI cells that were exposed 
in vivo to MC actually produced more progesterone (211 % of control). In addition, when 
TI cells, isolated from immature rats exposed to corn oil or 100 mg/kg MC for 6 
consecutive days and to PMSG during the last 2 days of exposure, were cultured in the 
absence of hCG, TI cells exposed in vivo to MC produced more progesterone than control 
cells (152 % control). 
In the first two in vitro studies, the exposure of isolated GC or TI cells from 2-day 
PMSG-primed immature female rats directly with the reported active metabolite HPTE 
(0, 10-100 nM) for 24 h resulted in the progressive decline in progesterone formation 
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(studies 1 and 2). These observations suggested that HPTE directly inhibits progesterone 
formation by rat ovarian cells, and this decline in progesterone corresponded to a decline 
in P450 cholesterol side-chain cleavage (P450scc) activity. Based on these results the 
current studies were conducted to determine whether the in vivo exposure of immature 
female rats to MC, the parent compound to HPTE, for a short duration (5 or 6 days) 
would lower serum progesterone or estradiol levels and/or inhibit ex vivo ovarian cell 
progesterone formation. In immature animals not primed with PMSG, the in vivo 
exposure to MC (0, 20, 100 or 200 mg/kg) progressively reduced serum progesterone at 
the 100 and 200 mg/kg doses in the current studies. Under the conditions used in this 
study where follicular maturation was not enhanced by treating animals with PMSG, 
most of the progesterone would be expected to originate from theca cells of maturing non 
antral follicles. In a previous study where MC (0, 100 - 500 mg/kg) was administered by 
gavage to adult female rats on days 1-8 of pregnancy, serum progesterone levels also 
decline beginning at the 100 mg/kg dose [5]; however, under these conditions, most of 
the progesterone would have originated from luteal tissue. In a follow-up study, adult 
female rats were exposed daily to in vivo MC (0, 25-500 mg/kg) during the first 8 days of 
pregnancy and serum and the ex vivo production of progesterone and estradiol by ovarian 
cells (which  would consist mainly of luteal cells) was determined [6]. Similar to the 
initial study, serum progesterone levels declined starting at the 50 mg/kg dose, then levels 
were progressively lower at higher doses of MC; however, serum estradiol levels were 
unaffected by exposure to MC. When minced ovarian tissue from these animals was 
incubated without or with hCG for 1 h, progesterone production in the tissue exposed in 
vivo to MC, was no different than control; however, both basal and hCG-stimulated 
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testosterone and estradiol formation from these same ovarian tissue declined starting at 
the exposure dose of 200 mg/kg MC [6]. This pattern of circulating and ovarian steroid 
levels suggested that the decline in serum progesterone was due to enhanced peripheral 
metabolism of progesterone by MC exposure and not from a direct effect on ovarian 
progesterone formation, while the pattern of ovarian testosterone and estradiol formation 
suggested that in vivo MC exposure may have direct effects on ovarian steroid production 
at a step(s) following progesterone formation. These observations may, in part, explain 
the pattern of steroid levels in serum and in incubated ovarian tissue following in vivo 
MC exposure of pregnant rats, but this is not adequate to explain the pattern of circulating 
steroid levels and ovarian cell steroid formation in the current studies. 
  
The observations that serum progesterone levels progressively declined in response to in 
vivo exposure to MC in the present studies and our previous in vitro results on cultured 
ovarian cells, supported the idea that MC has direct effects on ovarian steroidogenesis. 
However, the ex vivo incubation of ovarian cells from these animals demonstrated no 
decline of progesterone production, and, when these cells were stimulated with hCG, 
ovarian cells exposed to MC in vivo actually produced more progesterone than control 
cells. These results suggested that the decline in circulating progesterone levels may have 
resulted, in part, from the peripheral metabolism of the steroid, especially in the liver. In 
this regard, one pathway for metabolism in rodents is by 6β- or 16α- hydroxylation of 
progesterone [3,4], which are mediated by CYP3A and CYP2B enzymes, respectively 
[11], and both of which are induced by MC [12]. Although the induction of hepatic 
CYP3A and CYP2B by MC may explain, in part, the enhanced peripheral metabolism of 
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progesterone, this does not explain why the ex vivo formation of progesterone by ovarian 
cells was unaffected by in vivo MC exposure. In adult male rats, in vivo exposure to MC 
resulted in  a reduction in serum testosterone levels and a decline in the ex vivo Leydig 
cell testosterone formation and P450 cholesterol side-chain cleavage (P450scc) activity 
[7], supporting in vitro studies where HPTE directly inhibited testosterone formation by 
cultured rat Leydig cells [13,14]. Although it is possible that less HPTE is available in 
female rats to affect ovarian steroid production, both male and female rat livers possess 
P450 enzymes capable of metabolizing MC to HPTE and to other metabolites, although 
the male liver was reported to be more active [15,16]. It is possible also that MC is 
processed differently in ovarian tissue so that less HPTE is available locally to affect 
progesterone formation. 
  
Currently, we do not have an explanation for the ex vivo hCG-stimulated increase in 
progesterone formation by ovarian cells exposed in vivo to MC. In peripheral tissues such 
as the ovary and uterus, progesterone can be 'inactivated' by its conversation to 20α-
hydroxyprogesterone, which is a less active hormone, by 20α-hydroxysteroid 
dehydrogenase [2]. Thus, in cultured FSH-primed rat granulosa cells, an increase in 
progesterone accumulation was associated with the inhibition of 20α-hydroxysteroid 
dehydrogenase activity by prolactin [17]. The effect of MC on serum estradiol levels or 
ovarian cell estrogen formation have been mixed. In young mature female mice, the daily 
i.p. administration of MC for 20 days had no effect on serum estradiol levels even though 
atresia of antral follicles increased in relation to the dose of MC [8]. In pregnant rats, the 
administration of MC by gavage for 8 consecutive days during early pregnancy had no 
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effect on serum estradiol levels; however, the ex vivo incubation  of ovarian tissue 
isolated a day following treatment and incubated without or with hCG, demonstrated a 
reduction in estradiol production by cells exposed in vivo to MC [6].  It is noteworthy that 
the animal models used in these studies to evaluate the effects of in vivo MC exposure on 
serum estradiol levels were different than the current studies. Because serum 
progesterone levels were unaffected in animals exposed to MC and to PMSG for the last 
2 days of MC exposure, this would suggest that an enzymatic step following progesterone 
formation in the ovary was inhibited by MC to account for the decline in serum estradiol 
levels in the present studies. Another explanation to account for the decline in serum 
estradiol levels is that an enzyme(s) involved in the metabolism of estradiol was 
enhanced by MC exposure. 
 
In summary, the results of the present study demonstrate that the in vivo exposure of 
immature female rats to MC (where follicle maturation was not accelerated by treatment 
with PMSG), progressively lowers circulating progesterone levels. However, in PMSG-
primed immature rats exposed to MC, there is no change in serum progesterone levels, 
while serum estradiol levels declined modestly compared to control animals. In addition,  
the ex vivo formation of progesterone by TI cells from animals exposed to MC is higher 
than control cells in the presence of hCG. These results suggest that the maturational 
status of ovarian follicles may influence the overall effects of in vivo MC exposure on 
circulating steroid levels or of the steroid-producing capacity of ovarian cells. In addition, 
the effects of in vivo MC exposure on the peripheral metabolism of MC itself to potential 
active metabolites or of the metabolism of ovarian steroids to inactive products, may 
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affect changes in circulating steroid levels or the capacity of ovarian cells to secrete 
active steroids. These results suggest further that the pattern of active steroids secreted ex 
vivo by ovarian cells in response to MC exposure may differ from previously reported in 






































Figure 4. 1. Effect of MC on serum progesterone levels in immature female rats 
 
Animals (21-24 days of age) were exposed to MC (0, 20-200 mg/kg body weight) alone 
dissolved in corn oil by gavage once daily for 6 consecutive days. Each treatment group 
represents the mean ± S.E.M. of 5 samples (pooled blood from 2-3 animals per sample). 































































Figure 4. 2. Effect of MC on serum progesterone and estradiol levels in PMSG-
primed rats 
 
Animals (21-24 days of age) were exposed to MC (0 or 200 mg/kg body weight) 
dissolved in corn oil by gavage once daily for 6 consecutive days, and each animal 
received a single injection of PMSG (20 IU/0.1 ml, s.c.) ~ 48 h prior to blood collection. 
Each treatment group represents the mean ± S.E.M. of 5 samples (pooled blood from 2-3 
















































































Figure 4. 3. Effect of in vivo MC exposure on ex vivo theca-interstitial cell progesterone 
production 
Animals (21-24 days of age) were exposed by gavage to MC (0 or 100 mg/kg) for 5 consecutive 
days without PMSG (Panels A and B) or to MC (0 or 200 mg/kg) for 6 consecutive days plus a 
single s.c. injection of PMSG (20 IU/animal) given during the last 2 days of MC exposure (Panel C). 
Animals were sacrificed ~ 24 h following the last day of MC treatment and ovaries were removed 
for isolation of TI cells. TI cells were cultured for 24 h in the absence (Panel A and C) or presence of 
10 mIU/ml hCG (Panel B). Progesterone released into the medium was quantitated by RIA. Each 
treatment group represents the mean ± S.E.M. of 4 samples from at least three separate experiments. 
(c) P<0.001 when compared to the appropriate control group. 
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GENERAL DISCUSSION  
Results obtained from the first three in vitro studies demonstrated that HPTE directly 
inhibits progesterone formation by PMSG-primed rat ovarian cells, and this decline in 
progesterone corresponded to a decline in P450 cholesterol side-chain cleavage (P450scc) 
activity, which converts cholesterol to pregnenolone in the pathway of progesterone and 
estrogen biosynthesis. In addition, the percentage decrease in progesterone production 
was greater than the declines in estradiol and androgen formation suggesting that HPTE 
may increase the estrogen/progesterone ratio. Further, this effect of HPTE action could be 
observed at environmentally relevant concentrations (10-50 nM) and does not appear to 
be mediated through the ER or AR signaling pathways, the currently recognized modes 
of action of MC and HPTE. The results of the last study suggested that the in vivo 
exposure to MC lowers circulating progesterone levels in the immature rats not treated 
with gonadotropins, finding that is consistent with HPTE actions in the in vitro studies. 
However, the involvement of gonadotropins leads to an ex vivo increase in progesterone 
production by isolated ovarian theca cells and no change in circulating progesterone 
levels. This suggests that the pattern of active steroids secreted ex vivo by ovarian cells in 
response to MC exposure differs from the in vitro effects of MC/HPTE.   
 
The inhibition of HPTE does not appear to be cell specific since progesterone formation 
by GC, TI and luteal cells were all affected in the current studies. A recent study also 
reported that HPTE lowered FSH-stimulated progesterone formation by isolated GC from 
immature rats [55]. Besides follicular cells, previous in vitro studies on isolated rat 
Leydig cells demonstrated that basal and hCG-stimulated testosterone formation are 
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decreased by HPTE inhibition of P450scc activity. The parent compound of HPTE, MC, 
was also shown to inhibit P450scc activity in isolated mitochondria from the bovine 
adrenal cortex [90] and progesterone formation by porcine GC [56,57]. 
 
The present in vitro observations indicate that HPTE specifically inhibits the P450scc 
step in the pathway of converting cholesterol to androgens and estradiol without affecting 
other steps in the ovarian steroidogenic pathway. Our results support the observations of 
other studies reporting that HPTE did not affect StAR mRNA levels, the primary 
transporter of cholesterol into mitochondria in GC and Leydig cells [55,91]. Although our 
current studies found no effect of 100 nM HPTE on P450scc mRNA levels in TI cells, a 
recent study in cultured rat GC reported that FSH-stimulated P450scc mRNA levels were 
reduced following exposure to 10 µM HPTE for two days [55]. In this study, lower 
concentrations of HPTE (0.1 or 1 µM) were without effect [55]. In addition, the mRNA 
levels of 3β-hydroxysteroid dehydrogenase and P450 aromatase also were reduced in rat 
GC following treatment with 10 µM HPTE [55]. In contrast, Zachow et al reported 
declines in estradiol formation and P450aromatase mRNA levels following exposure of 
rat GC to 10 µM HPTE [55]. In the present in vitro studies, the conversion of testosterone 
to estradiol was not affected by 100 nM HPTE in GC suggesting that HPTE has no effect 
on aromatase activity. It should be noted that the concentration of HPTE used in the study 




Although there is general agreement that HPTE inhibits the P450scc step, the mechanism 
of action is not established. Because HPTE acts as an ERα agonist but is antagonistic to 
ERβ and AR, the receptor-linked actions of HPTE are plausible [54]. However, in the 
current study none of the estrogenic agents including 17β-estradiol itself, or the 
xenoestrogenic agents, bisphenol A or octylphenol, inhibited progesterone formation by 
TI cells or GC. In fact, bisphenol A or octylphenol modestly increased progesterone 
formation in TI cells, and when the “pure” estrogen antagonist ICI was added 
concomitantly with HPTE, it did not alter the inhibition by HPTE of progesterone 
formation. Similarly, the antiandrogenic agents, flutamide or M-2, had no effect on 
progesterone production by TI cells or GC. Collectively, these studies suggest that a 
receptor-mediated action of HPTE is unlikely. In agreement with our current results, a 
recent study also showed that exposure to estrogenic, antiestrogenic or antiandrogenic 
compounds did not alter androgen production by cultured rat Leydig cells [38], and the 
concomitant inclusion of ICI with HPTE did not block the inhibitive effects of HPTE.  In 
contrast, another study suggested that the inhibition of rat Leydig cell androgen 
production by HPTE was mediated through the ER pathway based on the observation that 
the concomitant inclusion of ICI blocked the effects of HPTE [91].  
 
The current observations suggest that HPTE directly inhibits P450scc catalytic activity, 
which, in turn, is responsible for a decline in progesterone formation by TI cells. This 
effect of HPTE on P450scc activity in TI cells is in agreement with the results of 
previously reported observations that the dose-dependent decline in testosterone 
formation in rat Leydig cells correlated with a similar pattern of decline in the activity of 
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this enzyme [37,38,58]. Although how HPTE specifically inhibits this step in the 
steroidogenic pathway is not known, a possible mode of HPTE action is to occupy the 
cholesterol-binding region of P450scc. To our knowledge, there is no study showing that 
HPTE covalently binds to P450scc, but HPTE was reported to bind covalently to liver 
microsomal proteins in the presence of NADPH [92]. Moreover, the parent compound 
MC was shown to inhibit P450scc activity of bovine adrenocortical mitochondria by 
binding near to the cholesterol-binding region of this enzyme [90]. In this study, the 
inhibition by MC was diminished by inclusion of exogenous cholesterol. However, in our 
studies, the addition of cholesterol as substrate did not prevent the inhibition by HPTE of 
TI cell progesterone formation.  
 
The observations that serum progesterone levels progressively declined in response to in 
vivo exposure to MC in the last study and the first three in vitro studies on cultured 
ovarian cells, supported the idea that MC/HPTE has direct effects on ovarian 
steroidogenesis. However, the ex vivo incubation of ovarian cells from MC-exposed 
animals demonstrated no decline in progesterone production, and, when these cells were 
stimulated with hCG, ovarian cells exposed to MC in vivo actually produced more 
progesterone than control cells. Under the conditions used in these studies where 
follicular maturation was not enhanced by treating animals with PMSG, most of the 
progesterone would be expected to originate from theca cells of maturing non-antral 
follicles. In a previous study where MC (0, 100 - 500 mg/kg) was administered by gavage 
to adult female rats on days 1-8 of pregnancy, serum progesterone levels also declined 
beginning at the 100 mg/kg dose [26]; however, under these conditions, most of the 
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progesterone would have originated from luteal tissue. In a follow-up study, adult female 
rats were exposed daily to in vivo MC (0, 25-500 mg/kg) during the first 8 days of 
pregnancy and serum and the ex vivo production of progesterone and estradiol by ovarian 
cells (which  would consist mainly of luteal cells) was determined [29]. Similar to the 
initial study, serum progesterone levels declined starting at the 50 mg/kg dose, then levels 
were progressively lower at higher doses of MC; however, serum estradiol levels were 
unaffected by exposure to MC. When minced ovarian tissue from these animals was 
incubated without or with hCG for 1 h, progesterone production in the tissue exposed in 
vivo to MC, was no different than control; however, both basal and hCG-stimulated 
testosterone and estradiol formation from these same ovarian tissue declined starting at 
the exposure dose of 200 mg/kg MC [29]. Taken together, it is possible that the decline in 
circulating progesterone levels may have resulted, in part, from the peripheral 
metabolism of the steroid, especially in the liver. In this regard, one pathway for 
metabolism in rodents is by 6β-  or 16α- hydroxylation of progesterone [86,87], which 
are mediated by CYP3A and CYP2B enzymes, respectively [88], and both of which are 
induced by MC [93]. Further, in peripheral tissues such as the ovary and uterus, 
progesterone can be 'inactivated' by its conversation to 20α-hydroxyprogesteorne, which 
is a less active hormone, by 20α-hydroxysteroid dehydrogenase [85]. However, this does 
not explain why the ex vivo formation of progesterone by ovarian cells was unaffected by 
in vivo MC exposure. In adult male rats, in vivo exposure to MC resulted in  a reduction 
in serum testosterone levels and a decline in the ex vivo Leydig cell testosterone 
formation and P450 cholesterol side-chain cleavage (P450scc) activity [58], supporting in 
vitro studies where HPTE directly inhibited testosterone formation by cultured rat Leydig 
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cells [37,38]. Although it is possible that less HPTE is available in female rats to affect 
ovarian steroid production, both male and female and rat livers posses P450 enzymes 
capable of metabolizing MC to HPTE and to other metabolites, although the male liver 
was reported to be more active [94,95]. It is possible also that MC is processed 
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